CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: beta-lactam
Accession: CHEBI:35627
browse the term
Definition: A lactam in which the amide bond is contained within a four-membered ring, which includes the amide nitrogen and the carbonyl carbon.
Synonyms: related_synonym: Formula=C3H2NOR3; SMILES=C1(C(N(*)C1*)=O)*; a beta-lactam; beta-lactams
alt_id: CHEBI:10426; CHEBI:13203; CHEBI:22845
xref: KEGG:C01866; Wikipedia:Beta-lactam
G
AMPD3
adenosine monophosphate deaminase 3
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of AMPD3 mRNA
CTD
PMID:24211530
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
FTH1
ferritin heavy chain 1
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of FTH1 mRNA
CTD
PMID:24211530
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of FTL mRNA
CTD
PMID:24211530
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of GCLM mRNA
CTD
PMID:24211530
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
HMOX1
heme oxygenase 1
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of HMOX1 mRNA
CTD
PMID:24211530
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of MYC mRNA
CTD
PMID:24211530
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of NQO1 mRNA
CTD
PMID:24211530
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
SEL1L3
SEL1L family member 3
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of SEL1L3 mRNA
CTD
PMID:24211530
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA
CTD
PMID:24211530
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SQSTM1
sequestosome 1
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of SQSTM1 mRNA
CTD
PMID:24211530
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SYNE2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA
CTD
PMID:24211530
NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
G
TNNT2
troponin T2, cardiac type
decreases expression
EXP
7-aminocephalosporanic acid results in decreased expression of TNNT2 mRNA
CTD
PMID:24211530
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TRIM16L
tripartite motif containing 16 like (pseudogene)
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of TRIM16L mRNA
CTD
PMID:24211530
NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,722,237...18,735,460 Ensembl chr17:18,722,237...18,735,460
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA
CTD
PMID:24211530
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
Amoxicillin results in increased expression of AKR1B10 mRNA
CTD
PMID:28444390
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKT1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of AKT1 protein
CTD
PMID:36529298
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
AMH
anti-Mullerian hormone
increases expression
ISO
Amoxicillin results in increased expression of AMH mRNA
CTD
PMID:36529298
NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
G
AQP5
aquaporin 5
decreases expression
ISO
Amoxicillin results in decreased expression of AQP5 protein
CTD
PMID:30031112
NCBI chr12:49,961,872...49,965,682
Ensembl chr12:49,961,872...49,965,682
G
CASP3
caspase 3
increases expression
ISO
Amoxicillin results in increased expression of CASP3 mRNA; Amoxicillin results in increased expression of CASP3 protein
CTD
PMID:36529298
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
decreases activity
ISO
Amoxicillin results in decreased activity of CAT protein
CTD
PMID:26429924
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CXCL10
C-X-C motif chemokine ligand 10
decreases expression
EXP
Amoxicillin results in decreased expression of CXCL10 mRNA
CTD
PMID:25091725
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Amoxicillin results in increased expression of CXCL8 mRNA; Amoxicillin results in increased expression of CXCL8 protein
CTD
PMID:11390425 PMID:25091725
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
decreases expression
ISO
Amoxicillin results in decreased expression of CYP11A1 mRNA
CTD
PMID:36529298
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP11B2
cytochrome P450 family 11 subfamily B member 2
increases expression
EXP
Amoxicillin results in increased expression of CYP11B2
CTD
PMID:17822730
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
decreases expression
ISO
Amoxicillin results in decreased expression of CYP17A1 mRNA
CTD
PMID:36529298
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
increases expression
EXP
Amoxicillin results in increased expression of CYP19A1
CTD
PMID:17822730
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
decreases activity multiple interactions
EXP
Amoxicillin results in decreased activity of CYP2C8 protein Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine]
CTD
PMID:26763401
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
GFRA1
GDNF family receptor alpha 1
decreases expression
ISO
Amoxicillin results in decreased expression of GFRA1 mRNA
CTD
PMID:36529298
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
GSR
glutathione-disulfide reductase
decreases activity
ISO
Amoxicillin results in decreased activity of GSR protein
CTD
PMID:32196862
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HLA-B
major histocompatibility complex, class I, B
affects expression
EXP
Amoxicillin affects the expression of HLA-B mRNA
CTD
PMID:25811541
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
affects expression
EXP
Amoxicillin affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:36529298
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
ISO
Amoxicillin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:36529298
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MKI67
marker of proliferation Ki-67
decreases expression
ISO
Amoxicillin results in decreased expression of MKI67 mRNA; Amoxicillin results in decreased expression of MKI67 protein
CTD
PMID:36529298
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Amoxicillin results in increased expression of NQO1 mRNA
CTD
PMID:28444390
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR5A1
nuclear receptor subfamily 5 group A member 1
decreases expression
ISO
Amoxicillin results in decreased expression of NR5A1 mRNA
CTD
PMID:36529298
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
G
PCNA
proliferating cell nuclear antigen
decreases expression
ISO
Amoxicillin results in decreased expression of PCNA mRNA; Amoxicillin results in decreased expression of PCNA protein
CTD
PMID:36529298
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
SLC51A
solute carrier family 51 member A
increases expression
EXP
Amoxicillin results in increased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SRXN1
sulfiredoxin 1
increases expression
EXP
Amoxicillin results in increased expression of SRXN1 mRNA
CTD
PMID:28444390
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
STAR
steroidogenic acute regulatory protein
decreases expression
ISO
Amoxicillin results in decreased expression of STAR mRNA; Amoxicillin results in decreased expression of STAR protein
CTD
PMID:36529298
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
G
ZBTB16
zinc finger and BTB domain containing 16
decreases expression
ISO
Amoxicillin results in decreased expression of ZBTB16 mRNA; Amoxicillin results in decreased expression of ZBTB16 protein
CTD
PMID:36529298
NCBI chr11:114,059,711...114,256,770
Ensembl chr11:114,059,041...114,256,765
G
ABCA1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCA1 mRNA
CTD
PMID:36464106
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB1A mRNA
CTD
PMID:36464106
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB11 mRNA
CTD
PMID:36464106
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA
CTD
PMID:36464106
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
decreases expression multiple interactions
EXP ISO
Ampicillin results in decreased expression of ABCC3 mRNA [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC3 mRNA
CTD
PMID:21632981 PMID:36464106
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Ampicillin
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA
CTD
PMID:36464106
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ABCG5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA
CTD
PMID:36464106
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ACAT2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein
CTD
PMID:30545405
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACE2
angiotensin converting enzyme 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein
CTD
PMID:30545405
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
AGER
advanced glycosylation end-product specific receptor
decreases expression
ISO
Ampicillin results in decreased expression of AGER mRNA
CTD
PMID:24747151
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AHSG
alpha 2-HS glycoprotein
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein
CTD
PMID:30545405
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
G
AKR1B10
aldo-keto reductase family 1 member B10
decreases expression
EXP
Ampicillin results in decreased expression of AKR1B10 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C2
aldo-keto reductase family 1 member C2
decreases expression
EXP
Ampicillin results in decreased expression of AKR1C2 mRNA
CTD
PMID:21632981
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
ALDOA
aldolase, fructose-bisphosphate A
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein
CTD
PMID:30545405
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ALDOB
aldolase, fructose-bisphosphate B
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein
CTD
PMID:30545405
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
G
AMOT
angiomotin
increases expression
EXP
Ampicillin results in increased expression of AMOT mRNA
CTD
PMID:21632981
NCBI chr X:112,774,877...112,840,831
Ensembl chr X:112,774,503...112,840,831
G
ANKRD1
ankyrin repeat domain 1
increases expression
EXP
Ampicillin results in increased expression of ANKRD1 mRNA
CTD
PMID:21632981
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
G
AQP3
aquaporin 3 (Gill blood group)
decreases expression
EXP
Ampicillin results in decreased expression of AQP3 mRNA
CTD
PMID:21632981
NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
G
ARG1
arginase 1
increases expression
EXP
Ampicillin results in increased expression of ARG1 mRNA
CTD
PMID:21632981
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARG2
arginase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein
CTD
PMID:30545405
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGDIA
Rho GDP dissociation inhibitor alpha
increases expression
EXP
Ampicillin results in increased expression of ARHGDIA mRNA
CTD
PMID:21632981
NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,721...81,871,378
G
ARPC3
actin related protein 2/3 complex subunit 3
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein
CTD
PMID:30545405
NCBI chr12:110,434,823...110,450,337
Ensembl chr12:110,434,823...110,450,422
G
ARRDC3
arrestin domain containing 3
decreases expression
EXP
Ampicillin results in decreased expression of ARRDC3 mRNA
CTD
PMID:21632981
NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317
G
ARRDC4
arrestin domain containing 4
decreases expression
EXP
Ampicillin results in decreased expression of ARRDC4 mRNA
CTD
PMID:21632981
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ASAH1
N-acylsphingosine amidohydrolase 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein
CTD
PMID:30545405
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
EXP
Ampicillin results in decreased expression of ASNS mRNA
CTD
PMID:21632981
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein
CTD
PMID:30545405
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
G
ATP2A3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein
CTD
PMID:30545405
NCBI chr17:3,923,873...3,964,437
Ensembl chr17:3,923,870...3,964,464
G
ATP5MF
ATP synthase membrane subunit f
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein
CTD
PMID:30545405
NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,186
G
ATP5PD
ATP synthase peripheral stalk subunit d
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PD protein
CTD
PMID:30545405
NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
G
ATP5PF
ATP synthase peripheral stalk subunit F6
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PF protein
CTD
PMID:30545405
NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
G
B3GALT5
beta-1,3-galactosyltransferase 5
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein
CTD
PMID:30545405
NCBI chr21:39,612,940...39,673,137
Ensembl chr21:39,556,442...39,673,137
G
BAX
BCL2 associated X, apoptosis regulator
increases response to substance
ISO
BAX results in increased susceptibility to Ampicillin
CTD
PMID:15731293
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BPIFB2
BPI fold containing family B member 2
increases expression
EXP
Ampicillin results in increased expression of BPIFB2 mRNA
CTD
PMID:21632981
NCBI chr20:33,007,704...33,023,703
Ensembl chr20:33,007,704...33,023,703
G
CA9
carbonic anhydrase 9
increases expression
EXP
Ampicillin results in increased expression of CA9 mRNA
CTD
PMID:21632981
NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
G
CALR
calreticulin
increases expression
EXP
Ampicillin results in increased expression of CALR mRNA
CTD
PMID:21632981
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CCN1
cellular communication network factor 1
increases expression
EXP
Ampicillin results in increased expression of CCN1 mRNA
CTD
PMID:21632981
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCPG1
cell cycle progression 1
decreases expression
EXP
Ampicillin results in decreased expression of CCPG1 mRNA
CTD
PMID:21632981
NCBI chr15:55,355,239...55,408,359
Ensembl chr15:55,340,032...55,408,510
G
CD40
CD40 molecule
increases expression
EXP
Ampicillin results in increased expression of CD40 mRNA
CTD
PMID:25091725
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CES1
carboxylesterase 1
increases expression
EXP
Ampicillin results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CHST15
carbohydrate sulfotransferase 15
increases expression
EXP
Ampicillin results in increased expression of CHST15 mRNA
CTD
PMID:21632981
NCBI chr10:124,007,668...124,093,598
Ensembl chr10:124,007,668...124,093,598
G
CKB
creatine kinase B
increases expression
EXP
Ampicillin results in increased expression of CKB mRNA
CTD
PMID:21632981
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CLCA4
chloride channel accessory 4
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein
CTD
PMID:30545405
NCBI chr 1:86,547,078...86,580,754
Ensembl chr 1:86,547,078...86,580,754
G
CLDN5
claudin 5
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
CTD
PMID:35390362
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLDN7
claudin 7
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein
CTD
PMID:30545405
NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
G
CLGN
calmegin
decreases expression
EXP
Ampicillin results in decreased expression of CLGN mRNA
CTD
PMID:21632981
NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661
G
CLIC3
chloride intracellular channel 3
increases expression
EXP
Ampicillin results in increased expression of CLIC3 mRNA
CTD
PMID:21632981
NCBI chr 9:136,994,608...136,996,568
Ensembl chr 9:136,994,608...136,996,568
G
CMBL
carboxymethylenebutenolidase homolog
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein
CTD
PMID:30545405
NCBI chr 5:10,277,595...10,307,902
Ensembl chr 5:10,275,875...10,307,902
G
CNDP2
carnosine dipeptidase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein
CTD
PMID:30545405
NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454
G
COX5A
cytochrome c oxidase subunit 5A
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein
CTD
PMID:30545405
NCBI chr15:74,919,791...74,938,073
Ensembl chr15:74,919,791...74,938,083
G
COX6B1
cytochrome c oxidase subunit 6B1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein
CTD
PMID:30545405
NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782
G
COX7A2
cytochrome c oxidase subunit 7A2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein
CTD
PMID:30545405
NCBI chr 6:75,237,675...75,250,298
Ensembl chr 6:75,237,675...75,250,323
G
CP
ceruloplasmin
increases expression
EXP
Ampicillin results in increased expression of CP mRNA
CTD
PMID:21632981
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CREB3L3
cAMP responsive element binding protein 3 like 3
decreases expression
EXP
Ampicillin results in decreased expression of CREB3L3 mRNA
CTD
PMID:21632981
NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,631...4,173,054
G
CSF2
colony stimulating factor 2
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein
CTD
PMID:31442584
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSTA
cystatin A
decreases expression
EXP
Ampicillin results in decreased expression of CSTA mRNA
CTD
PMID:21632981
NCBI chr 3:122,325,248...122,341,969
Ensembl chr 3:122,325,248...122,341,969
G
CTSA
cathepsin A
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein
CTD
PMID:30545405
NCBI chr20:45,891,335...45,898,820
Ensembl chr20:45,890,144...45,898,949
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
ISO
Ampicillin results in increased expression of CXCL2 mRNA
CTD
PMID:24747151
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Ampicillin results in increased expression of CXCL8 mRNA
CTD
PMID:25091725
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
decreases expression
EXP
Ampicillin results in decreased expression of CYP1A1 mRNA
CTD
PMID:21632981
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA
CTD
PMID:30545405
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
decreases expression
EXP
Ampicillin results in decreased expression of CYP24A1 mRNA
CTD
PMID:21632981
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA
CTD
PMID:36464106
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2C18
cytochrome P450 family 2 subfamily C member 18
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA
CTD
PMID:30545405
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA
CTD
PMID:30545405
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA
CTD
PMID:30545405
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA
CTD
PMID:36464106
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7B1 mRNA
CTD
PMID:36464106
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA
CTD
PMID:36464106
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DKK1
dickkopf WNT signaling pathway inhibitor 1
increases expression
EXP
Ampicillin results in increased expression of DKK1 mRNA
CTD
PMID:21632981
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
Ampicillin results in increased expression of DUSP1 mRNA
CTD
PMID:21632981
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP7
dual specificity phosphatase 7
increases expression
EXP
Ampicillin results in increased expression of DUSP7 mRNA
CTD
PMID:21632981
NCBI chr 3:52,048,919...52,056,571
Ensembl chr 3:52,048,919...52,056,571
G
EDN1
endothelin 1
increases expression
EXP
Ampicillin results in increased expression of EDN1 mRNA
CTD
PMID:21632981
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EPCAM
epithelial cell adhesion molecule
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein
CTD
PMID:30545405
NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
G
ESM1
endothelial cell specific molecule 1
decreases expression
EXP
Ampicillin results in decreased expression of ESM1 mRNA
CTD
PMID:21632981
NCBI chr 5:54,977,867...54,985,593
Ensembl chr 5:54,977,867...55,022,671
G
ETFA
electron transfer flavoprotein subunit alpha
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein
CTD
PMID:30545405
NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730
G
EZR
ezrin
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein
CTD
PMID:30545405
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
G
FASN
fatty acid synthase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA
CTD
PMID:36464106
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FILIP1L
filamin A interacting protein 1 like
increases expression
EXP
Ampicillin results in increased expression of FILIP1L mRNA
CTD
PMID:21632981
NCBI chr 3:99,828,811...100,114,501
Ensembl chr 3:99,828,811...100,114,513
G
FXYD1
FXYD domain containing ion transport regulator 1
increases expression
EXP
Ampicillin results in increased expression of FXYD1 mRNA
CTD
PMID:21632981
NCBI chr19:35,137,188...35,143,109
Ensembl chr19:35,138,824...35,143,109
G
GCLC
glutamate-cysteine ligase catalytic subunit
decreases expression
EXP
Ampicillin results in decreased expression of GCLC mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
decreases expression increases expression
EXP
Ampicillin results in decreased expression of GCLM mRNA Ampicillin results in increased expression of GCLM mRNA
CTD
PMID:21632981 PMID:22609641
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GFPT2
glutamine-fructose-6-phosphate transaminase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein
CTD
PMID:30545405
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
G
GIPC2
GIPC PDZ domain containing family member 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein
CTD
PMID:30545405
NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,444
G
GNG12
G protein subunit gamma 12
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein
CTD
PMID:30545405
NCBI chr 1:67,701,475...67,833,467
Ensembl chr 1:67,701,475...67,833,467
G
GPAT3
glycerol-3-phosphate acyltransferase 3
decreases expression
EXP
Ampicillin results in decreased expression of GPAT3 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 4:83,535,587...83,605,875
Ensembl chr 4:83,535,914...83,605,875
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein
CTD
PMID:36464106
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein
CTD
PMID:30545405
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GSTM2
glutathione S-transferase mu 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA
CTD
PMID:30545405
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
HEXB
hexosaminidase subunit beta
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein
CTD
PMID:30545405
NCBI chr 5:74,640,023...74,721,288
Ensembl chr 5:74,640,023...74,722,647
G
HLA-DMB
major histocompatibility complex, class II, DM beta
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein
CTD
PMID:30545405
NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
G
HMGB1
high mobility group box 1
increases expression
ISO
Ampicillin results in increased expression of HMGB1 protein
CTD
PMID:24747151
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA
CTD
PMID:36464106
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
increases expression
EXP
Ampicillin results in increased expression of HMOX1 mRNA
CTD
PMID:25091725
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPH2
heterogeneous nuclear ribonucleoprotein H2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein
CTD
PMID:30545405
NCBI chr X:101,408,222...101,414,133
Ensembl chr X:101,408,222...101,414,133
G
HOXD1
homeobox D1
increases expression
EXP
Ampicillin results in increased expression of HOXD1 mRNA
CTD
PMID:21632981
NCBI chr 2:176,188,668...176,190,907
Ensembl chr 2:176,188,668...176,190,907
G
HP
haptoglobin
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein
CTD
PMID:30545405
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
IFRD1
interferon related developmental regulator 1
decreases expression
EXP
Ampicillin results in decreased expression of IFRD1 mRNA
CTD
PMID:21632981
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IGFBP3
insulin like growth factor binding protein 3
increases expression
EXP
Ampicillin results in increased expression of IGFBP3 mRNA
CTD
PMID:21632981
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IL18
interleukin 18
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein]
CTD
PMID:35390362
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
multiple interactions increases expression
ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein]] [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA] Ampicillin results in increased expression of IL1B mRNA
CTD
PMID:21893697 PMID:24747151 PMID:35390362
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein]
CTD
PMID:31442584
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
JDP2
Jun dimerization protein 2
decreases expression
EXP
Ampicillin results in decreased expression of JDP2 mRNA
CTD
PMID:21632981
NCBI chr14:75,426,943...75,474,107
Ensembl chr14:75,427,716...75,474,111
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Ampicillin results in increased expression of JUND mRNA
CTD
PMID:21632981
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
KRT16
keratin 16
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein
CTD
PMID:30545405
NCBI chr17:41,609,778...41,612,767
Ensembl chr17:41,609,778...41,615,899
G
LAIR2
leukocyte associated immunoglobulin like receptor 2
decreases expression
EXP
Ampicillin results in decreased expression of LAIR2 mRNA
CTD
PMID:21632981
NCBI chr19:54,502,831...54,510,687
Ensembl chr19:54,497,879...54,510,687
G
LCN15
lipocalin 15
increases expression
EXP
Ampicillin results in increased expression of LCN15 mRNA
CTD
PMID:21632981
NCBI chr 9:136,759,634...136,764,518
Ensembl chr 9:136,759,634...136,766,255
G
LDLR
low density lipoprotein receptor
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA
CTD
PMID:36464106
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LOX
lysyl oxidase
increases expression
EXP
Ampicillin results in increased expression of LOX mRNA
CTD
PMID:21632981
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPIN1
lipin 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA
CTD
PMID:36464106
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
LYZ
lysozyme
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein
CTD
PMID:30545405
NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein
CTD
PMID:30545405
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAZ
MYC associated zinc finger protein
increases expression
EXP
Ampicillin results in increased expression of MAZ mRNA
CTD
PMID:21632981
NCBI chr16:29,806,124...29,811,164
Ensembl chr16:29,806,106...29,811,164
G
MIR22HG
MIR22 host gene
decreases expression
EXP
Ampicillin results in decreased expression of MIR22HG mRNA
CTD
PMID:21632981
NCBI chr17:1,711,504...1,716,272
Ensembl chr17:1,711,447...1,717,174
G
MPO
myeloperoxidase
multiple interactions
ISO
Ampicillin inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:11686837 PMID:11991626 PMID:18306037
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MTSS2
MTSS I-BAR domain containing 2
increases expression
EXP
Ampicillin results in increased expression of MTSS2 mRNA
CTD
PMID:21632981
NCBI chr16:70,661,204...70,686,053
Ensembl chr16:70,661,204...70,686,053
G
MYD88
MYD88 innate immune signal transduction adaptor
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
CTD
PMID:35390362
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
MYH14
myosin heavy chain 14
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein
CTD
PMID:30545405
NCBI chr19:50,203,622...50,310,540
Ensembl chr19:50,188,186...50,310,542
G
NDUFA13
NADH:ubiquinone oxidoreductase subunit A13
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein
CTD
PMID:30545405
NCBI chr19:19,516,225...19,528,198
Ensembl chr19:19,515,736...19,529,054
G
NDUFAB1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein
CTD
PMID:30545405
NCBI chr16:23,581,014...23,596,316
Ensembl chr16:23,581,014...23,596,316
G
NHERF2
NHERF family PDZ scaffold protein 2
increases expression
EXP
Ampicillin results in increased expression of NHERF2 mRNA
CTD
PMID:21632981
NCBI chr16:2,026,902...2,039,026
Ensembl chr16:2,025,356...2,039,026
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]
CTD
PMID:11686837 PMID:12568917 PMID:15610444 PMID:16944022 PMID:18306037 PMID:21893697 More...
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NPC2
NPC intracellular cholesterol transporter 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein
CTD
PMID:30545405
NCBI chr14:74,479,935...74,493,512
Ensembl chr14:74,476,192...74,494,177
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Ampicillin results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OCLN
occludin
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]
CTD
PMID:35390362
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
PA2G4
proliferation-associated 2G4
increases expression
EXP
Ampicillin results in increased expression of PA2G4 mRNA
CTD
PMID:21632981
NCBI chr12:56,104,559...56,113,910
Ensembl chr12:56,104,537...56,113,910
G
PABPC1L
poly(A) binding protein cytoplasmic 1 like
decreases expression
EXP
Ampicillin results in decreased expression of PABPC1L mRNA
CTD
PMID:21632981
NCBI chr20:44,910,060...44,939,316
Ensembl chr20:44,910,060...44,959,035
G
PDP2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
EXP
Ampicillin results in increased expression of PDP2 mRNA
CTD
PMID:21632981
NCBI chr16:66,880,515...66,891,101
Ensembl chr16:66,878,589...66,895,754
G
PDXK
pyridoxal kinase
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PDXK protein
CTD
PMID:30545405
NCBI chr21:43,737,000...43,738,097
Ensembl chr21:43,719,094...43,762,307
G
PFKFB3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression
EXP
Ampicillin results in increased expression of PFKFB3 mRNA
CTD
PMID:21632981
NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,934...6,254,644
G
PFN1
profilin 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein
CTD
PMID:30545405
NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061
G
PGAM1
phosphoglycerate mutase 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein
CTD
PMID:30545405
NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444
G
PGC
progastricsin
increases expression
EXP
Ampicillin results in increased expression of PGC mRNA
CTD
PMID:21632981
NCBI chr 6:41,736,711...41,747,397
Ensembl chr 6:41,736,711...41,754,109
G
PGD
phosphogluconate dehydrogenase
decreases activity
ISO
Ampicillin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
PIR
pirin
increases expression
EXP
Ampicillin results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PKM
pyruvate kinase M1/2
increases expression
EXP
Ampicillin results in increased expression of PKM mRNA
CTD
PMID:21632981
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
G
PLPPR1
phospholipid phosphatase related 1
increases expression
EXP
Ampicillin results in increased expression of PLPPR1 mRNA
CTD
PMID:21632981
NCBI chr 9:101,028,727...101,325,135
Ensembl chr 9:101,028,727...101,325,135
G
PMM2
phosphomannomutase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein
CTD
PMID:30545405
NCBI chr16:8,797,839...8,849,325
Ensembl chr16:8,788,823...8,862,534
G
PON1
paraoxonase 1
decreases activity
ISO EXP
Ampicillin results in decreased activity of PON1 protein
CTD
PMID:16880604 PMID:31581362
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PPP1CA
protein phosphatase 1 catalytic subunit alpha
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein
CTD
PMID:30545405
NCBI chr11:67,398,183...67,401,858
Ensembl chr11:67,398,181...67,421,183
G
PPP1CB
protein phosphatase 1 catalytic subunit beta
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein
CTD
PMID:30545405
NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940
G
PPP1CC
protein phosphatase 1 catalytic subunit gamma
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein
CTD
PMID:30545405
NCBI chr12:110,708,376...110,742,891
Ensembl chr12:110,719,680...110,742,939
G
PSMA3
proteasome 20S subunit alpha 3
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein
CTD
PMID:30545405
NCBI chr14:58,244,843...58,272,004
Ensembl chr14:58,244,843...58,272,012
G
PTGR1
prostaglandin reductase 1
decreases expression
EXP
Ampicillin results in decreased expression of PTGR1 mRNA
CTD
PMID:21632981
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; Ampicillin inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA]
CTD
PMID:15610444 PMID:21893697
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTMS
parathymosin
increases expression
EXP
Ampicillin results in increased expression of PTMS mRNA
CTD
PMID:21632981
NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952
G
RALB
RAS like proto-oncogene B
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein
CTD
PMID:30545405
NCBI chr 2:120,240,070...120,294,710
Ensembl chr 2:120,240,064...120,294,710
G
RAN
RAN, member RAS oncogene family
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein
CTD
PMID:30545405
NCBI chr12:130,872,066...130,877,678
Ensembl chr12:130,872,037...130,877,678
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
CTD
PMID:35390362
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RGCC
regulator of cell cycle
increases expression
EXP
Ampicillin results in increased expression of RGCC mRNA
CTD
PMID:21632981
NCBI chr13:41,457,550...41,470,871
Ensembl chr13:41,457,550...41,470,871
G
RIDA
reactive intermediate imine deaminase A homolog
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein
CTD
PMID:30545405
NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
G
RPL30
ribosomal protein L30
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein
CTD
PMID:30545405
NCBI chr 8:98,041,721...98,045,545
Ensembl chr 8:98,024,851...98,046,469
G
RPN2
ribophorin II
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein
CTD
PMID:30545405
NCBI chr20:37,179,330...37,241,619
Ensembl chr20:37,178,410...37,241,619
G
RPS23
ribosomal protein S23
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein
CTD
PMID:30545405
NCBI chr 5:82,273,320...82,278,354
Ensembl chr 5:82,273,320...82,278,396
G
RPS27L
ribosomal protein S27 like
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein
CTD
PMID:30545405
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
S100A10
S100 calcium binding protein A10
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein
CTD
PMID:30545405
NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
G
S100A11
S100 calcium binding protein A11
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein
CTD
PMID:30545405
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
G
S100A9
S100 calcium binding protein A9
increases expression
ISO
Ampicillin results in increased expression of S100A9 mRNA
CTD
PMID:24747151
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SAMD1
sterile alpha motif domain containing 1
increases expression
EXP
Ampicillin results in increased expression of SAMD1 mRNA
CTD
PMID:21632981
NCBI chr19:14,087,851...14,090,751
Ensembl chr19:14,087,851...14,091,036
G
SCARB2
scavenger receptor class B member 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein
CTD
PMID:30545405
NCBI chr 4:76,158,737...76,234,532
Ensembl chr 4:76,158,737...76,234,536
G
SERPINB6
serpin family B member 6
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein
CTD
PMID:30545405
NCBI chr 6:2,948,159...2,971,793
Ensembl chr 6:2,948,159...2,972,165
G
SGK2
serum/glucocorticoid regulated kinase 2
decreases expression
EXP
Ampicillin results in decreased expression of SGK2 mRNA
CTD
PMID:21632981
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
G
SHMT2
serine hydroxymethyltransferase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein
CTD
PMID:30545405
NCBI chr12:57,229,711...57,234,935
Ensembl chr12:57,229,573...57,234,935
G
SLC1A2
solute carrier family 1 member 2
increases expression
EXP
Ampicillin results in increased expression of SLC1A2 protein
CTD
PMID:17138558
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
G
SLC22A15
solute carrier family 22 member 15
decreases expression
EXP
Ampicillin results in decreased expression of SLC22A15 mRNA
CTD
PMID:21632981
NCBI chr 1:115,976,513...116,070,054
Ensembl chr 1:115,976,513...116,070,054
G
SLC22A7
solute carrier family 22 member 7
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SLC22A7 mRNA
CTD
PMID:36464106
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SLC25A20
solute carrier family 25 member 20
multiple interactions
ISO
Ampicillin binds to and results in decreased activity of SLC25A20 protein; Ampicillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
G
SLC2A3
solute carrier family 2 member 3
increases expression
EXP
Ampicillin results in increased expression of SLC2A3 mRNA
CTD
PMID:21632981
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC3A1
solute carrier family 3 member 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein
CTD
PMID:30545405
NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494
G
SLC6A14
solute carrier family 6 member 14
increases expression
EXP
Ampicillin results in increased expression of SLC6A14 mRNA
CTD
PMID:21632981
NCBI chr X:116,436,606...116,461,458
Ensembl chr X:116,436,606...116,461,458
G
SLC6A8
solute carrier family 6 member 8
increases expression
EXP
Ampicillin results in increased expression of SLC6A8 mRNA
CTD
PMID:21632981
NCBI chr X:153,687,926...153,696,593
Ensembl chr X:153,687,926...153,696,588
G
SLC7A11
solute carrier family 7 member 11
decreases expression
EXP
Ampicillin results in decreased expression of SLC7A11 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SMIM14
small integral membrane protein 14
decreases expression
EXP
Ampicillin results in decreased expression of SMIM14 mRNA
CTD
PMID:21632981
NCBI chr 4:39,546,336...39,638,865
Ensembl chr 4:39,546,336...39,638,902
G
SMPD2
sphingomyelin phosphodiesterase 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein
CTD
PMID:30545405
NCBI chr 6:109,440,724...109,443,919
Ensembl chr 6:109,440,724...109,443,919
G
SQLE
squalene epoxidase
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SQLE mRNA
CTD
PMID:36464106
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA
CTD
PMID:36464106
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF2 mRNA
CTD
PMID:36464106
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
SRXN1
sulfiredoxin 1
decreases expression
EXP
Ampicillin results in decreased expression of SRXN1 mRNA
CTD
PMID:21632981 PMID:26198647
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
TAGLN
transgelin
increases expression
EXP
Ampicillin results in increased expression of TAGLN mRNA
CTD
PMID:21632981
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TARS1
threonyl-tRNA synthetase 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS1 protein
CTD
PMID:30545405
NCBI chr 5:33,440,696...33,468,091
Ensembl chr 5:33,440,696...33,468,091
G
TIMP1
TIMP metallopeptidase inhibitor 1
decreases expression
EXP
Ampicillin results in decreased expression of TIMP1 mRNA
CTD
PMID:21632981
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TJP1
tight junction protein 1
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]
CTD
PMID:35390362
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TLR4
toll like receptor 4
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]; TLR4 gene mutant form results in decreased susceptibility to [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin]
CTD
PMID:35390362
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TM9SF2
transmembrane 9 superfamily member 2
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein
CTD
PMID:30545405
NCBI chr13:99,501,472...99,564,048
Ensembl chr13:99,446,311...99,564,048
G
TMED10
transmembrane p24 trafficking protein 10
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein
CTD
PMID:30545405
NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,469...75,176,612
G
TNF
tumor necrosis factor
multiple interactions
ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]] [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of TNF protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein]
CTD
PMID:21893697 PMID:31442584 PMID:35390362
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TPM4
tropomyosin 4
increases expression
EXP
Ampicillin results in increased expression of TPM4 mRNA
CTD
PMID:21632981
NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,002
G
TRAF6
TNF receptor associated factor 6
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 protein]
CTD
PMID:35390362
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
G
TRIM16
tripartite motif containing 16
increases expression
EXP
Ampicillin results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
G
TTYH3
tweety family member 3
increases expression
EXP
Ampicillin results in increased expression of TTYH3 mRNA
CTD
PMID:21632981
NCBI chr 7:2,631,986...2,664,802
Ensembl chr 7:2,631,961...2,664,802
G
TUBAL3
tubulin alpha like 3
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein
CTD
PMID:30545405
NCBI chr10:5,393,101...5,404,828
Ensembl chr10:5,393,101...5,404,828
G
TUBB1
tubulin beta 1 class VI
increases expression
EXP
Ampicillin results in increased expression of TUBB1 mRNA
CTD
PMID:21632981
NCBI chr20:59,016,438...59,026,654
Ensembl chr20:59,019,429...59,026,654
G
TUBE1
tubulin epsilon 1
decreases expression
EXP
Ampicillin results in decreased expression of TUBE1 mRNA
CTD
PMID:21632981
NCBI chr 6:112,070,663...112,087,482
Ensembl chr 6:112,070,663...112,087,529
G
TWF1
twinfilin actin binding protein 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein
CTD
PMID:30545405
NCBI chr12:43,793,723...43,806,317
Ensembl chr12:43,793,723...43,806,328
G
TXNDC5
thioredoxin domain containing 5
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein
CTD
PMID:30545405
NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
G
UQCRC1
ubiquinol-cytochrome c reductase core protein 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein
CTD
PMID:30545405
NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
G
UQCRFS1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein
CTD
PMID:30545405
NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
G
UQCRH
ubiquinol-cytochrome c reductase hinge protein
multiple interactions
ISO
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein
CTD
PMID:30545405
NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]; Ampicillin inhibits the reaction [Celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]]
CTD
PMID:21893697
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VLDLR
very low density lipoprotein receptor
decreases expression
EXP
Ampicillin results in decreased expression of VLDLR mRNA
CTD
PMID:21632981
NCBI chr 9:2,621,787...2,660,056
Ensembl chr 9:2,621,182...2,660,056
G
ABCB11
ATP binding cassette subfamily B member 11
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
CASP3
caspase 3
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein
CTD
PMID:30273099
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP9
caspase 9
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein
CTD
PMID:30273099
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of CXCL8 protein
CTD
PMID:11390425
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYCS
cytochrome c, somatic
increases secretion
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein
CTD
PMID:30273099
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA
CTD
PMID:34767876
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
FGF19
fibroblast growth factor 19
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA
CTD
PMID:34767876
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA
CTD
PMID:34767876
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GCLC
glutamate-cysteine ligase catalytic subunit
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA
CTD
PMID:34767876
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA
CTD
PMID:34767876
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GGT1
gamma-glutamyltransferase 1
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein
CTD
PMID:34767876
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GOT1
glutamic-oxaloacetic transaminase 1
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein
CTD
PMID:30273099
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GPT
glutamic--pyruvic transaminase
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein
CTD
PMID:30273099
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX2
glutathione peroxidase 2
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA
CTD
PMID:34767876
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GSR
glutathione-disulfide reductase
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA
CTD
PMID:34767876
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
ME1
malic enzyme 1
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA
CTD
PMID:34767876
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
NR0B2
nuclear receptor subfamily 0 group B member 2
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA
CTD
PMID:34767876
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
SLC10A1
solute carrier family 10 member 1
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC51A
solute carrier family 51 member A
decreases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA
CTD
PMID:34767876
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
TKT
transketolase
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA
CTD
PMID:34767876
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA
CTD
PMID:34767876
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
ABCC2
ATP binding cassette subfamily C member 2
increases expression
ISO
Aztreonam results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCG5
ATP binding cassette subfamily G member 5
increases expression
ISO
Aztreonam results in increased expression of ABCG5 mRNA
CTD
PMID:24657338
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
increases expression
ISO
Aztreonam results in increased expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
affects expression
EXP
Aztreonam affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
decreases expression
ISO
Aztreonam results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr 7:44,512,535...44,541,330
Ensembl chr 7:44,512,535...44,541,330
G
NR5A2
nuclear receptor subfamily 5 group A member 2
increases expression
ISO
Aztreonam results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
SLC10A1
solute carrier family 10 member 1
increases expression
ISO
Aztreonam results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC10A2
solute carrier family 10 member 2
decreases expression
ISO
Aztreonam results in decreased expression of SLC10A2 mRNA
CTD
PMID:24657338
NCBI chr13:103,043,998...103,066,417
Ensembl chr13:103,043,998...103,066,417
G
SLC51B
SLC51 subunit beta
decreases expression
ISO
Aztreonam results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
G
ABCC2
ATP binding cassette subfamily C member 2
increases activity multiple interactions
ISO EXP
Penicillin G results in increased activity of ABCC2 protein Penicillin G promotes the reaction [ABCC2 protein affects the transport of estradiol-17 beta-glucuronide]
CTD
PMID:12702717 PMID:15904671
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Penicillin G
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ACACA
acetyl-CoA carboxylase alpha
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of ACACA mRNA Penicillin G results in increased expression of ACACA mRNA
CTD
PMID:27503388
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
G
ACLY
ATP citrate lyase
increases expression multiple interactions
ISO
Penicillin G results in increased expression of ACLY mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA
CTD
PMID:27503388
NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
G
AFP
alpha fetoprotein
affects expression decreases expression
ISO EXP
Penicillin G affects the expression of AFP mRNA Penicillin G results in decreased expression of AFP mRNA
CTD
PMID:24737281 PMID:25137620 PMID:26272751
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
G
ANXA8
annexin A8
decreases expression
EXP
Penicillin G results in decreased expression of ANXA8 mRNA
CTD
PMID:24737281
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
G
ATF3
activating transcription factor 3
increases expression
EXP
Penicillin G results in increased expression of ATF3 mRNA
CTD
PMID:27965148
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
CCL2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CCL2 mRNA Penicillin G results in increased expression of CCL2 mRNA
CTD
PMID:27503388
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCR2
C-C motif chemokine receptor 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CCR2 mRNA
CTD
PMID:27503388
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CD36
CD36 molecule (CD36 blood group)
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CD36 mRNA Penicillin G results in increased expression of CD36 mRNA
CTD
PMID:27503388
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD86
CD86 molecule
increases expression
EXP
Penicillin G results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CER1
cerberus 1, DAN family BMP antagonist
increases expression
ISO
Penicillin G results in increased expression of CER1 mRNA
CTD
PMID:26272751
NCBI chr 9:14,717,326...14,722,733
Ensembl chr 9:14,719,724...14,722,733
G
CES1
carboxylesterase 1
increases expression
EXP
Penicillin G results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CPT1A
carnitine palmitoyltransferase 1A
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CPT1A mRNA
CTD
PMID:27503388
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CRP
C-reactive protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CRP mRNA
CTD
PMID:27503388
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CS
citrate synthase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of CS mRNA Penicillin G results in increased expression of CS mRNA
CTD
PMID:27503388
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression increases secretion
EXP
SB 203580 affects the reaction [Penicillin G results in increased secretion of CXCL8 protein] Penicillin G results in increased expression of CXCL8 mRNA; Penicillin G results in increased expression of CXCL8 protein
CTD
PMID:18494145 PMID:22609641 PMID:27965148
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
DCN
decorin
decreases expression
EXP
Penicillin G results in decreased expression of DCN mRNA
CTD
PMID:24737281
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DEFB1
defensin beta 1
decreases expression multiple interactions
ISO
Penicillin G results in decreased expression of DEFB1 mRNA [Penicillin G co-treated with Erythromycin] results in decreased expression of DEFB1 mRNA
CTD
PMID:27503388
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
G
DGAT1
diacylglycerol O-acyltransferase 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT1 mRNA
CTD
PMID:27503388
NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910
G
DGAT2
diacylglycerol O-acyltransferase 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of DGAT2 mRNA
CTD
PMID:27503388
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
FABP1
fatty acid binding protein 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of FABP1 mRNA
CTD
PMID:27503388
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FASN
fatty acid synthase
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of FASN mRNA Penicillin G results in increased expression of FASN mRNA
CTD
PMID:27503388
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FRZB
frizzled related protein
decreases expression
EXP
Penicillin G results in decreased expression of FRZB mRNA
CTD
PMID:24737281
NCBI chr 2:182,833,275...182,866,637
Ensembl chr 2:182,833,275...182,866,637
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Penicillin G results in increased expression of GCLM mRNA
CTD
PMID:22609641
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GPAM
glycerol-3-phosphate acyltransferase, mitochondrial
increases expression multiple interactions
ISO
Penicillin G results in increased expression of GPAM mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of GPAM mRNA
CTD
PMID:27503388
NCBI chr10:112,149,865...112,227,677
Ensembl chr10:112,149,865...112,215,377
G
HDAC7
histone deacetylase 7
increases expression
ISO
Penicillin G results in increased expression of HDAC7 mRNA
CTD
PMID:26272751
NCBI chr12:47,782,722...47,821,344
Ensembl chr12:47,782,722...47,833,132
G
IFNG
interferon gamma
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of IFNG mRNA Penicillin G results in increased expression of IFNG mRNA
CTD
PMID:27503388
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF2
insulin like growth factor 2
decreases expression
EXP
Penicillin G results in decreased expression of IGF2 mRNA
CTD
PMID:24737281
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IGFBP5
insulin like growth factor binding protein 5
decreases expression
EXP
Penicillin G results in decreased expression of IGFBP5 mRNA
CTD
PMID:24737281
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IL18
interleukin 18
increases expression
EXP
Penicillin G results in increased expression of IL18 protein
CTD
PMID:23063874
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
increases expression multiple interactions
ISO
Penicillin G results in increased expression of IL1A mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of IL1A mRNA
CTD
PMID:27503388
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases expression
EXP
Penicillin G results in increased expression of IL1B mRNA
CTD
PMID:22609641
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of IL6 mRNA
CTD
PMID:27503388
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Penicillin G results in increased expression of JUN mRNA
CTD
PMID:26272751
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KDR
kinase insert domain receptor
increases expression decreases expression
ISO
Penicillin G results in increased expression of KDR mRNA Penicillin G results in decreased expression of KDR mRNA
CTD
PMID:25137620 PMID:26272751
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
LBP
lipopolysaccharide binding protein
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of LBP mRNA
CTD
PMID:27503388
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
G
MESP1
mesoderm posterior bHLH transcription factor 1
decreases expression
ISO
Penicillin G results in decreased expression of MESP1 mRNA
CTD
PMID:26272751
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
G
MMP1
matrix metallopeptidase 1
decreases expression
EXP
Penicillin G results in decreased expression of MMP1 mRNA
CTD
PMID:24737281
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MTTP
microsomal triglyceride transfer protein
increases expression multiple interactions
ISO
Penicillin G results in increased expression of MTTP mRNA [Penicillin G co-treated with Erythromycin] results in increased expression of MTTP mRNA
CTD
PMID:27503388
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
G
MUC2
mucin 2, oligomeric mucus/gel-forming
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of MUC2 mRNA
CTD
PMID:27503388
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Penicillin G results in increased expression of MYC mRNA
CTD
PMID:26272751
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NEFM
neurofilament medium chain
affects expression
ISO
Penicillin G affects the expression of NEFM mRNA
CTD
PMID:25137620
NCBI chr 8:24,913,761...24,919,093
Ensembl chr 8:24,913,758...24,919,098
G
NES
nestin
increases expression affects expression
ISO
Penicillin G results in increased expression of NES protein Penicillin G affects the expression of NES mRNA
CTD
PMID:16137769 PMID:16369854 PMID:25137620
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of NFKB1 mRNA Penicillin G results in increased expression of NFKB1 mRNA
CTD
PMID:27503388
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Penicillin G results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
PGD
phosphogluconate dehydrogenase
decreases activity
ISO
Penicillin G results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
PIR
pirin
increases expression
EXP
Penicillin G results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PNPLA6
patatin like phospholipase domain containing 6
decreases expression
ISO
Penicillin G results in decreased expression of PNPLA6 mRNA
CTD
PMID:25137620
NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764
G
REG3G
regenerating family member 3 gamma
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of REG3G mRNA
CTD
PMID:27503388
NCBI chr 2:79,025,702...79,028,501
Ensembl chr 2:79,025,686...79,028,505
G
RETNLB
resistin like beta
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in decreased expression of RETNLB mRNA
CTD
PMID:27503388
NCBI chr 3:108,755,638...108,757,410
Ensembl chr 3:108,743,424...108,757,410
G
SHH
sonic hedgehog signaling molecule
increases expression
ISO
Penicillin G results in increased expression of SHH mRNA
CTD
PMID:26272751
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SLC22A12
solute carrier family 22 member 12
multiple interactions
ISO
Potassium promotes the reaction [SLC22A12 protein results in increased uptake of Penicillin G]
CTD
PMID:15284287
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
G
SLC22A20P
solute carrier family 22 member 20, pseudogene
multiple interactions
ISO
Penicillin G inhibits the reaction [SLC22A20 protein results in increased uptake of estrone sulfate]
CTD
PMID:16478971
NCBI chr11:65,213,840...65,242,757
Ensembl chr11:65,213,873...65,242,086
G
SLC22A6
solute carrier family 22 member 6
multiple interactions
EXP
Penicillin G inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:11602689
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO EXP
Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Famotidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Ranitidine]; Probenecid inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G]; tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G] resveratrol inhibits the reaction [SLC22A8 protein results in increased uptake of Penicillin G]
CTD
PMID:10224140 PMID:15319347 PMID:17255469 PMID:27377006 PMID:35019195
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC27A2
solute carrier family 27 member 2
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SLC27A2 mRNA
CTD
PMID:27503388
NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385
G
SLCO3A1
solute carrier organic anion transporter family member 3A1
multiple interactions
EXP
Penicillin G promotes the reaction [SLCO3A1 protein results in increased uptake of simvastatin acid]
CTD
PMID:28887287
NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of SREBF1 mRNA
CTD
PMID:27503388
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
TLR4
toll like receptor 4
multiple interactions
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of TLR4 mRNA
CTD
PMID:27503388
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions increases expression
ISO
[Penicillin G co-treated with Erythromycin] results in increased expression of TNF mRNA Penicillin G results in increased expression of TNF mRNA
CTD
PMID:27503388
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TRIM16
tripartite motif containing 16
increases expression
EXP
Penicillin G results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
G
TTR
transthyretin
decreases expression
EXP
Penicillin G results in decreased expression of TTR mRNA
CTD
PMID:24737281
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
G
WNT3
Wnt family member 3
increases expression
ISO
Penicillin G results in increased expression of WNT3 mRNA
CTD
PMID:26272751
NCBI chr17:46,762,506...46,818,692
Ensembl chr17:46,762,506...46,833,154
G
APEH
acylaminoacyl-peptide hydrolase
multiple interactions decreases activity
EXP
Carbapenems inhibits the reaction [APEH protein results in increased metabolism of valproic acid glucuronide] Carbapenems results in decreased activity of APEH protein
CTD
PMID:20551238
NCBI chr 3:49,673,117...49,683,971
Ensembl chr 3:49,674,014...49,683,971
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
EXP
Cefaclor inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Cefaclor results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
increases expression
EXP
Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
SLC22A6
solute carrier family 22 member 6
multiple interactions
EXP
Cefaclor inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of Cefaclor Cefaclor inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
increases expression
EXP
Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
HLA-B
major histocompatibility complex, class I, B
affects expression
EXP
Cefadroxil affects the expression of HLA-B mRNA
CTD
PMID:25811541
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-G
major histocompatibility complex, class I, G
affects expression
EXP
Cefadroxil affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
AADAC
arylacetamide deacetylase
increases expression
ISO
Cephaloridine results in increased expression of AADAC mRNA
CTD
PMID:18500788
NCBI chr 3:151,814,116...151,828,488
Ensembl chr 3:151,814,073...151,828,488
G
AASS
aminoadipate-semialdehyde synthase
decreases expression
ISO
Cephaloridine results in decreased expression of AASS mRNA
CTD
PMID:18500788
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
G
ABCC2
ATP binding cassette subfamily C member 2
increases expression
ISO
Cephaloridine results in increased expression of ABCC2 mRNA
CTD
PMID:18500788
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ACMSD
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
ISO
Cephaloridine results in decreased expression of ACMSD mRNA
CTD
PMID:18500788
NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034
G
ACOT9
acyl-CoA thioesterase 9
increases expression
ISO
Cephaloridine results in increased expression of ACOT9 mRNA
CTD
PMID:18500788
NCBI chr X:23,701,055...23,743,276
Ensembl chr X:23,701,055...23,766,475
G
ACSM5
acyl-CoA synthetase medium chain family member 5
decreases expression
ISO
Cephaloridine results in decreased expression of ACSM5 mRNA
CTD
PMID:18500788
NCBI chr16:20,409,534...20,441,336
Ensembl chr16:20,409,534...20,441,336
G
ADAM8
ADAM metallopeptidase domain 8
decreases expression
ISO
Cephaloridine results in decreased expression of ADAM8 mRNA
CTD
PMID:18500788
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADGRE1
adhesion G protein-coupled receptor E1
increases expression
ISO
Cephaloridine results in increased expression of ADGRE1 mRNA
CTD
PMID:18500788
NCBI chr19:6,887,579...6,940,450
Ensembl chr19:6,887,566...6,940,459
G
ADORA2A
adenosine A2a receptor
increases expression
ISO
Cephaloridine results in increased expression of ADORA2A mRNA
CTD
PMID:18500788
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADRA1D
adrenoceptor alpha 1D
increases expression
ISO
Cephaloridine results in increased expression of ADRA1D mRNA
CTD
PMID:18500788
NCBI chr20:4,220,630...4,249,287
Ensembl chr20:4,220,630...4,249,287
G
AFTPH
aftiphilin
decreases expression
ISO
Cephaloridine results in decreased expression of AFTPH mRNA
CTD
PMID:18500788
NCBI chr 2:64,524,328...64,593,005
Ensembl chr 2:64,524,299...64,593,005
G
AKR1B1
aldo-keto reductase family 1 member B
increases expression
ISO
Cephaloridine results in increased expression of AKR1B1 mRNA
CTD
PMID:18172885
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR1D1
aldo-keto reductase family 1 member D1
increases expression
ISO
Cephaloridine results in increased expression of AKR1D1 mRNA
CTD
PMID:18172885
NCBI chr 7:138,076,459...138,118,305
Ensembl chr 7:138,002,324...138,118,305
G
ALAS1
5'-aminolevulinate synthase 1
increases expression
ISO
Cephaloridine results in increased expression of ALAS1 mRNA
CTD
PMID:18500788
NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
increases expression
ISO
Cephaloridine results in increased expression of ALDH3A1 mRNA
CTD
PMID:18500788
NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
G
ALDH3B1
aldehyde dehydrogenase 3 family member B1
increases expression
ISO
Cephaloridine results in increased expression of ALDH3B1 mRNA
CTD
PMID:18500788
NCBI chr11:68,008,547...68,029,276
Ensembl chr11:68,008,578...68,029,282
G
ALDOA
aldolase, fructose-bisphosphate A
affects expression
ISO
Cephaloridine affects the expression of ALDOA mRNA
CTD
PMID:18172885
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
AMER2
APC membrane recruitment protein 2
decreases expression
ISO
Cephaloridine results in decreased expression of AMER2 mRNA
CTD
PMID:18500788
NCBI chr13:25,161,679...25,172,288
Ensembl chr13:25,161,679...25,172,288
G
AMIGO2
adhesion molecule with Ig like domain 2
increases expression
ISO
Cephaloridine results in increased expression of AMIGO2 mRNA
CTD
PMID:18500788
NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959
G
AMPD1
adenosine monophosphate deaminase 1
increases expression
ISO
Cephaloridine results in increased expression of AMPD1 mRNA
CTD
PMID:18500788
NCBI chr 1:114,673,098...114,695,546
Ensembl chr 1:114,673,090...114,695,618
G
AMPD3
adenosine monophosphate deaminase 3
increases expression
ISO
Cephaloridine results in increased expression of AMPD3 mRNA
CTD
PMID:18500788
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
ANGPTL4
angiopoietin like 4
increases expression
ISO
Cephaloridine results in increased expression of ANGPTL4 mRNA
CTD
PMID:18500788
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
G
ANLN
anillin, actin binding protein
decreases expression
ISO
Cephaloridine results in decreased expression of ANLN mRNA
CTD
PMID:18500788
NCBI chr 7:36,389,862...36,453,791
Ensembl chr 7:36,389,821...36,453,791
G
ANXA13
annexin A13
decreases expression
ISO
Cephaloridine results in decreased expression of ANXA13 mRNA
CTD
PMID:18500788
NCBI chr 8:123,680,794...123,737,393
Ensembl chr 8:123,680,794...123,737,402
G
ANXA7
annexin A7
increases expression
ISO
Cephaloridine results in increased expression of ANXA7 mRNA
CTD
PMID:18500788
NCBI chr10:73,375,101...73,414,058
Ensembl chr10:73,375,101...73,414,076
G
APCS
amyloid P component, serum
decreases expression
ISO
Cephaloridine results in decreased expression of APCS mRNA
CTD
PMID:18500788
NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865
G
APOA4
apolipoprotein A4
increases expression
ISO
Cephaloridine results in increased expression of APOA4 mRNA
CTD
PMID:18500788
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOB
apolipoprotein B
increases expression
ISO
Cephaloridine results in increased expression of APOB mRNA
CTD
PMID:18500788
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC2
apolipoprotein C2
increases expression
ISO
Cephaloridine results in increased expression of APOC2 mRNA
CTD
PMID:18500788
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOLD1
apolipoprotein L domain containing 1
decreases expression
ISO
Cephaloridine results in decreased expression of APOLD1 mRNA
CTD
PMID:18500788
NCBI chr12:12,725,917...12,791,466
Ensembl chr12:12,725,917...12,829,975
G
ARFGEF3
ARFGEF family member 3
decreases expression
ISO
Cephaloridine results in decreased expression of ARFGEF3 mRNA
CTD
PMID:18500788
NCBI chr 6:138,161,939...138,344,663
Ensembl chr 6:138,161,939...138,344,663
G
ARHGAP35
Rho GTPase activating protein 35
decreases expression
ISO
Cephaloridine results in decreased expression of ARHGAP35 mRNA
CTD
PMID:18500788
NCBI chr19:46,860,997...47,005,077
Ensembl chr19:46,860,997...47,005,077
G
ARID5A
AT-rich interaction domain 5A
increases expression
ISO
Cephaloridine results in increased expression of ARID5A mRNA
CTD
PMID:18500788
NCBI chr 2:96,536,752...96,552,638
Ensembl chr 2:96,536,743...96,552,634
G
ASF1B
anti-silencing function 1B histone chaperone
increases expression
ISO
Cephaloridine results in increased expression of ASF1B mRNA
CTD
PMID:18500788
NCBI chr19:14,119,512...14,136,589
Ensembl chr19:14,119,512...14,136,613
G
ASH1L
ASH1 like histone lysine methyltransferase
decreases expression
ISO
Cephaloridine results in decreased expression of ASH1L mRNA
CTD
PMID:18500788
NCBI chr 1:155,335,268...155,563,202
Ensembl chr 1:155,335,268...155,563,162
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Cephaloridine results in increased expression of ASNS mRNA
CTD
PMID:18500788
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ATAD1
ATPase family AAA domain containing 1
increases expression
ISO
Cephaloridine results in increased expression of ATAD1 mRNA
CTD
PMID:18500788
NCBI chr10:87,751,512...87,841,361
Ensembl chr10:87,751,512...87,841,361
G
ATAD2
ATPase family AAA domain containing 2
increases expression
ISO
Cephaloridine results in increased expression of ATAD2 mRNA
CTD
PMID:18500788
NCBI chr 8:123,319,850...123,416,350
Ensembl chr 8:123,319,850...123,416,350
G
ATF3
activating transcription factor 3
decreases expression
ISO
Cephaloridine results in decreased expression of ATF3 mRNA
CTD
PMID:18500788
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
ATL1
atlastin GTPase 1
increases expression
ISO
Cephaloridine results in increased expression of ATL1 mRNA
CTD
PMID:18500788
NCBI chr14:50,533,082...50,633,068
Ensembl chr14:50,532,509...50,634,017
G
ATP11C
ATPase phospholipid transporting 11C
decreases expression
ISO
Cephaloridine results in decreased expression of ATP11C mRNA
CTD
PMID:18500788
NCBI chr X:139,726,348...139,936,903
Ensembl chr X:139,726,346...139,945,276
G
ATP12A
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
ISO
Cephaloridine results in increased expression of ATP12A mRNA
CTD
PMID:18500788
NCBI chr13:24,680,408...24,712,472
Ensembl chr13:24,680,408...24,712,472
G
AURKB
aurora kinase B
decreases expression
ISO
Cephaloridine results in decreased expression of AURKB mRNA
CTD
PMID:18500788
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
G
B3GALT2
beta-1,3-galactosyltransferase 2
decreases expression
ISO
Cephaloridine results in decreased expression of B3GALT2 mRNA
CTD
PMID:18500788
NCBI chr 1:193,178,730...193,186,613
Ensembl chr 1:193,178,730...193,186,613
G
B3GNT7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
decreases expression
ISO
Cephaloridine results in decreased expression of B3GNT7 mRNA
CTD
PMID:18500788
NCBI chr 2:231,395,710...231,401,164
Ensembl chr 2:231,395,710...231,401,164
G
BAG3
BAG cochaperone 3
increases expression
ISO
Cephaloridine results in increased expression of BAG3 mRNA
CTD
PMID:18500788
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
G
BAK1
BCL2 antagonist/killer 1
increases expression
ISO
Cephaloridine results in increased expression of BAK1 mRNA
CTD
PMID:18500788
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BARD1
BRCA1 associated RING domain 1
increases expression
ISO
Cephaloridine results in increased expression of BARD1 mRNA
CTD
PMID:18500788
NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
G
BATF
basic leucine zipper ATF-like transcription factor
increases expression
ISO
Cephaloridine results in increased expression of BATF mRNA
CTD
PMID:18500788
NCBI chr14:75,522,469...75,546,992
Ensembl chr14:75,522,455...75,546,993
G
BCL2L1
BCL2 like 1
affects expression
ISO
Cephaloridine affects the expression of BCL2L1 mRNA
CTD
PMID:18172885
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BEX1
brain expressed X-linked 1
increases expression
ISO
Cephaloridine results in increased expression of BEX1 mRNA
CTD
PMID:18500788
NCBI chr X:103,062,651...103,064,171
Ensembl chr X:103,062,651...103,064,171
G
BEX4
brain expressed X-linked 4
increases expression
ISO
Cephaloridine results in increased expression of BEX4 mRNA
CTD
PMID:18500788
NCBI chr X:103,215,092...103,217,246
Ensembl chr X:103,215,108...103,217,246
G
BHLHE41
basic helix-loop-helix family member e41
increases expression
ISO
Cephaloridine results in increased expression of BHLHE41 mRNA
CTD
PMID:18500788
NCBI chr12:26,120,030...26,125,037
Ensembl chr12:26,120,030...26,125,037
G
BIRC3
baculoviral IAP repeat containing 3
increases expression
ISO
Cephaloridine results in increased expression of BIRC3 mRNA
CTD
PMID:18500788
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
BLVRB
biliverdin reductase B
increases expression
ISO
Cephaloridine results in increased expression of BLVRB mRNA
CTD
PMID:18500788
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
G
BPI
bactericidal permeability increasing protein
increases expression
ISO
Cephaloridine results in increased expression of BPI mRNA
CTD
PMID:18500788
NCBI chr20:38,304,156...38,337,505
Ensembl chr20:38,304,150...38,337,505
G
BRIP1
BRCA1 interacting helicase 1
increases expression
ISO
Cephaloridine results in increased expression of BRIP1 mRNA
CTD
PMID:18500788
NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559
G
BSND
barttin CLCNK type accessory subunit beta
increases expression
ISO
Cephaloridine results in increased expression of BSND mRNA
CTD
PMID:18500788
NCBI chr 1:54,998,933...55,017,172
Ensembl chr 1:54,998,933...55,017,172
G
BTG2
BTG anti-proliferation factor 2
decreases expression
ISO
Cephaloridine results in decreased expression of BTG2 mRNA
CTD
PMID:18500788
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
Cephaloridine results in decreased expression of BUB1B mRNA
CTD
PMID:18500788
NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
G
C16orf89
chromosome 16 open reading frame 89
increases expression
ISO
Cephaloridine results in increased expression of C10H16ORF89 mRNA
CTD
PMID:18500788
NCBI chr16:5,042,772...5,065,956
Ensembl chr16:5,044,122...5,066,110
G
C1QTNF1
C1q and TNF related 1
increases expression
ISO
Cephaloridine results in increased expression of C1QTNF1 mRNA
CTD
PMID:18500788
NCBI chr17:79,022,934...79,049,788
Ensembl chr17:79,022,814...79,049,788
G
C5
complement C5
decreases expression
ISO
Cephaloridine results in decreased expression of C5 mRNA
CTD
PMID:18500788
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
C6
complement C6
increases expression
ISO
Cephaloridine results in increased expression of C6 mRNA
CTD
PMID:18500788
NCBI chr 5:41,142,116...41,261,469
Ensembl chr 5:41,142,116...41,261,438
G
CACNA1H
calcium voltage-gated channel subunit alpha1 H
increases expression
ISO
Cephaloridine results in increased expression of CACNA1H mRNA
CTD
PMID:18500788
NCBI chr16:1,153,106...1,221,768
Ensembl chr16:1,153,103...1,224,169
G
CACNG3
calcium voltage-gated channel auxiliary subunit gamma 3
increases expression
ISO
Cephaloridine results in increased expression of CACNG3 mRNA
CTD
PMID:18500788
NCBI chr16:24,256,335...24,362,412
Ensembl chr16:24,256,335...24,362,412
G
CALB1
calbindin 1
increases expression
ISO
Cephaloridine results in increased expression of CALB1 mRNA
CTD
PMID:18500788
NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475
G
CALB2
calbindin 2
decreases expression
ISO
Cephaloridine results in decreased expression of CALB2 mRNA
CTD
PMID:18500788
NCBI chr16:71,358,723...71,390,433
Ensembl chr16:71,358,713...71,390,436
G
CALR
calreticulin
increases expression
ISO
Cephaloridine results in increased expression of CALR mRNA
CTD
PMID:18172885
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CAMKV
CaM kinase like vesicle associated
increases expression
ISO
Cephaloridine results in increased expression of CAMKV mRNA
CTD
PMID:18500788
NCBI chr 3:49,857,989...49,869,906
Ensembl chr 3:49,857,988...49,869,935
G
CANX
calnexin
increases expression
ISO
Cephaloridine results in increased expression of CANX mRNA
CTD
PMID:18172885
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
G
CAT
catalase
affects expression
ISO
Cephaloridine affects the expression of CAT protein
CTD
PMID:9933756
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL17
C-C motif chemokine ligand 17
increases expression
ISO
Cephaloridine results in increased expression of CCL17 mRNA
CTD
PMID:18500788
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL19
C-C motif chemokine ligand 19
increases expression
ISO
Cephaloridine results in increased expression of CCL19 mRNA
CTD
PMID:18500788
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
G
CCL20
C-C motif chemokine ligand 20
increases expression
ISO
Cephaloridine results in increased expression of CCL20 mRNA
CTD
PMID:18500788
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL28
C-C motif chemokine ligand 28
increases expression
ISO
Cephaloridine results in increased expression of CCL28 mRNA
CTD
PMID:18500788
NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391
G
CCL3
C-C motif chemokine ligand 3
decreases expression
ISO
Cephaloridine results in decreased expression of CCL3 mRNA
CTD
PMID:18500788
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
decreases expression
ISO
Cephaloridine results in decreased expression of CCL4 mRNA
CTD
PMID:18500788
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCN2
cellular communication network factor 2
decreases expression
ISO
Cephaloridine results in decreased expression of CCN2 mRNA
CTD
PMID:18500788
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNA2
cyclin A2
decreases expression
ISO
Cephaloridine results in decreased expression of CCNA2 mRNA
CTD
PMID:18500788
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCNB1
cyclin B1
decreases expression
ISO
Cephaloridine results in decreased expression of CCNB1 mRNA
CTD
PMID:18500788
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNB2
cyclin B2
decreases expression
ISO
Cephaloridine results in decreased expression of CCNB2 mRNA
CTD
PMID:18500788
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCNE1
cyclin E1
increases expression
ISO
Cephaloridine results in increased expression of CCNE1 mRNA
CTD
PMID:18500788
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CCNE2
cyclin E2
increases expression
ISO
Cephaloridine results in increased expression of CCNE2 mRNA
CTD
PMID:18500788
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CD52
CD52 molecule
decreases expression
ISO
Cephaloridine results in decreased expression of CD52 mRNA
CTD
PMID:18500788
NCBI chr 1:26,317,958...26,320,523
Ensembl chr 1:26,317,958...26,320,523
G
CD72
CD72 molecule
increases expression
ISO
Cephaloridine results in increased expression of CD72 mRNA
CTD
PMID:18500788
NCBI chr 9:35,609,982...35,646,857
Ensembl chr 9:35,609,982...35,646,810
G
CD86
CD86 molecule
increases expression
ISO
Cephaloridine results in increased expression of CD86 mRNA
CTD
PMID:18500788
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CDC42
cell division cycle 42
decreases expression
ISO
Cephaloridine results in decreased expression of CDC42 mRNA
CTD
PMID:18172885
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
G
CDC45
cell division cycle 45
increases expression
ISO
Cephaloridine results in increased expression of CDC45 mRNA
CTD
PMID:18500788
NCBI chr22:19,479,466...19,520,612
Ensembl chr22:19,479,457...19,520,612
G
CDC6
cell division cycle 6
increases expression
ISO
Cephaloridine results in increased expression of CDC6 mRNA
CTD
PMID:18500788
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
G
CDCA2
cell division cycle associated 2
decreases expression
ISO
Cephaloridine results in decreased expression of CDCA2 mRNA
CTD
PMID:18500788
NCBI chr 8:25,458,931...25,507,917
Ensembl chr 8:25,459,199...25,507,911
G
CDK1
cyclin dependent kinase 1
decreases expression
ISO
Cephaloridine results in decreased expression of CDK1 mRNA
CTD
PMID:18500788
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDKL1
cyclin dependent kinase like 1
decreases expression
ISO
Cephaloridine results in decreased expression of CDKL1 mRNA
CTD
PMID:18500788
NCBI chr14:50,326,265...50,397,298
Ensembl chr14:50,326,265...50,416,461
G
CDKN1A
cyclin dependent kinase inhibitor 1A
decreases expression
ISO
Cephaloridine results in decreased expression of CDKN1A mRNA
CTD
PMID:18500788
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
decreases expression
ISO
Cephaloridine results in decreased expression of CDKN1B mRNA
CTD
PMID:18500788
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CDT1
chromatin licensing and DNA replication factor 1
increases expression
ISO
Cephaloridine results in increased expression of CDT1 mRNA
CTD
PMID:18500788
NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258
G
CEACAM16
CEA cell adhesion molecule 16, tectorial membrane component
increases expression
ISO
Cephaloridine results in increased expression of CEACAM16 mRNA
CTD
PMID:18500788
NCBI chr19:44,699,151...44,710,718
Ensembl chr19:44,699,151...44,710,718
G
CENPK
centromere protein K
increases expression
ISO
Cephaloridine results in increased expression of CENPK mRNA
CTD
PMID:18500788
NCBI chr 5:65,495,624...65,563,168
Ensembl chr 5:65,517,766...65,563,168
G
CENPQ
centromere protein Q
increases expression
ISO
Cephaloridine results in increased expression of CENPQ mRNA
CTD
PMID:18500788
NCBI chr 6:49,463,370...49,493,107
Ensembl chr 6:49,463,370...49,493,107
G
CFAP263
cilia and flagella associated protein 263
increases expression
ISO
Cephaloridine results in increased expression of CCDC113 mRNA
CTD
PMID:18500788
NCBI chr16:58,249,936...58,283,836
Ensembl chr16:58,231,157...58,283,836
G
CHAF1A
chromatin assembly factor 1 subunit A
increases expression
ISO
Cephaloridine results in increased expression of CHAF1A mRNA
CTD
PMID:18500788
NCBI chr19:4,402,640...4,450,830
Ensembl chr19:4,402,640...4,445,018
G
CHAF1B
chromatin assembly factor 1 subunit B
increases expression
ISO
Cephaloridine results in increased expression of CHAF1B mRNA
CTD
PMID:18500788
NCBI chr21:36,385,392...36,419,015
Ensembl chr21:36,385,392...36,419,015
G
CHD4
chromodomain helicase DNA binding protein 4
decreases expression
ISO
Cephaloridine results in decreased expression of CHD4 mRNA
CTD
PMID:18500788
NCBI chr12:6,570,082...6,607,379
Ensembl chr12:6,570,082...6,614,524
G
CHD6
chromodomain helicase DNA binding protein 6
decreases expression
ISO
Cephaloridine results in decreased expression of CHD6 mRNA
CTD
PMID:18500788
NCBI chr20:41,402,083...41,618,377
Ensembl chr20:41,402,083...41,618,384
G
CHEK1
checkpoint kinase 1
increases expression
ISO
Cephaloridine results in increased expression of CHEK1 mRNA
CTD
PMID:18500788
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
G
CHST7
carbohydrate sulfotransferase 7
decreases expression
ISO
Cephaloridine results in decreased expression of CHST7 mRNA
CTD
PMID:18500788
NCBI chr X:46,573,765...46,598,496
Ensembl chr X:46,573,765...46,598,496
G
CHTF18
chromosome transmission fidelity factor 18
increases expression
ISO
Cephaloridine results in increased expression of CHTF18 mRNA
CTD
PMID:18500788
NCBI chr16:788,620...798,074
Ensembl chr16:788,046...800,737
G
CILP
cartilage intermediate layer protein
decreases expression
ISO
Cephaloridine results in decreased expression of CILP mRNA
CTD
PMID:18500788
NCBI chr15:65,194,760...65,211,473
Ensembl chr15:65,194,760...65,211,473
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
increases expression
ISO
Cephaloridine results in increased expression of CITED2 mRNA
CTD
PMID:18172885
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
CKAP2
cytoskeleton associated protein 2
decreases expression
ISO
Cephaloridine results in decreased expression of CKAP2 mRNA
CTD
PMID:18500788
NCBI chr13:52,455,478...52,476,627
Ensembl chr13:52,455,429...52,476,628
G
CLDN14
claudin 14
increases expression
ISO
Cephaloridine results in increased expression of CLDN14 mRNA
CTD
PMID:18500788
NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569
G
CLSTN2
calsyntenin 2
decreases expression
ISO
Cephaloridine results in decreased expression of CLSTN2 mRNA
CTD
PMID:18500788
NCBI chr 3:139,935,185...140,577,397
Ensembl chr 3:139,935,185...140,577,397
G
CMIP
c-Maf inducing protein
decreases expression
ISO
Cephaloridine results in decreased expression of CMIP mRNA
CTD
PMID:18500788
NCBI chr16:81,444,808...81,711,762
Ensembl chr16:81,444,808...81,711,762
G
CNDP1
carnosine dipeptidase 1
decreases expression
ISO
Cephaloridine results in decreased expression of CNDP1 mRNA
CTD
PMID:18500788
NCBI chr18:74,534,500...74,587,212
Ensembl chr18:74,534,500...74,587,212
G
COL4A4
collagen type IV alpha 4 chain
decreases expression
ISO
Cephaloridine results in decreased expression of COL4A4 mRNA
CTD
PMID:18500788
NCBI chr 2:226,967,360...227,164,488
Ensembl chr 2:227,002,714...227,164,453
G
COL7A1
collagen type VII alpha 1 chain
increases expression
ISO
Cephaloridine results in increased expression of COL7A1 mRNA
CTD
PMID:18500788
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
CPT1B
carnitine palmitoyltransferase 1B
increases expression
ISO
Cephaloridine results in increased expression of CPT1B mRNA
CTD
PMID:18500788
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
G
CRABP1
cellular retinoic acid binding protein 1
increases expression
ISO
Cephaloridine results in increased expression of CRABP1 mRNA
CTD
PMID:18500788
NCBI chr15:78,340,353...78,348,225
Ensembl chr15:78,340,353...78,348,225
G
CREBBP
CREB binding protein
decreases expression
ISO
Cephaloridine results in decreased expression of CREBBP mRNA
CTD
PMID:18500788
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
CRY1
cryptochrome circadian regulator 1
increases expression
ISO
Cephaloridine results in increased expression of CRY1 mRNA
CTD
PMID:18500788
NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549
G
CXCL1
C-X-C motif chemokine ligand 1
decreases expression
ISO
Cephaloridine results in decreased expression of CXCL1 mRNA
CTD
PMID:18500788
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
increases expression
ISO
Cephaloridine results in increased expression of CXCL10 mRNA
CTD
PMID:18500788
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL13
C-X-C motif chemokine ligand 13
increases expression
ISO
Cephaloridine results in increased expression of CXCL13 mRNA
CTD
PMID:18500788
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
G
CXCL14
C-X-C motif chemokine ligand 14
increases expression
ISO
Cephaloridine results in increased expression of CXCL14 mRNA
CTD
PMID:18500788
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
G
CXXC4
CXXC finger protein 4
decreases expression
ISO
Cephaloridine results in decreased expression of CXXC4 mRNA
CTD
PMID:18500788
NCBI chr 4:104,468,308...104,494,894
Ensembl chr 4:104,468,308...104,494,901
G
CYB5A
cytochrome b5 type A
increases expression
ISO
Cephaloridine results in increased expression of CYB5A mRNA
CTD
PMID:18172885
NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,973
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
increases expression
ISO
Cephaloridine results in increased expression of CYP1B1 mRNA
CTD
PMID:18500788
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
decreases expression
ISO
Cephaloridine results in decreased expression of CYP24A1 mRNA
CTD
PMID:18500788
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
G
CYP2C18
cytochrome P450 family 2 subfamily C member 18
decreases expression
ISO
Cephaloridine results in decreased expression of CYP2C mRNA
CTD
PMID:18500788
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
G
CYP7B1
cytochrome P450 family 7 subfamily B member 1
increases expression
ISO
Cephaloridine results in increased expression of CYP7B1 mRNA
CTD
PMID:18500788
NCBI chr 8:64,586,575...64,798,737
Ensembl chr 8:64,587,763...64,798,737
G
DCTPP1
dCTP pyrophosphatase 1
increases expression
ISO
Cephaloridine results in increased expression of DCTPP1 mRNA
CTD
PMID:18500788
NCBI chr16:30,423,615...30,430,030
Ensembl chr16:30,423,615...30,430,030
G
DDC
dopa decarboxylase
decreases expression
ISO
Cephaloridine results in decreased expression of DDC mRNA
CTD
PMID:18500788
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
G
DDIT4
DNA damage inducible transcript 4
decreases expression
ISO
Cephaloridine results in decreased expression of DDIT4 mRNA
CTD
PMID:18500788
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDIT4L
DNA damage inducible transcript 4 like
increases expression
ISO
Cephaloridine results in increased expression of DDIT4L mRNA
CTD
PMID:18500788
NCBI chr 4:100,185,870...100,190,468
Ensembl chr 4:100,185,870...100,190,782
G
DDX39A
DExD-box helicase 39A
increases expression
ISO
Cephaloridine results in increased expression of DDX39A mRNA
CTD
PMID:18500788
NCBI chr19:14,408,798...14,419,383
Ensembl chr19:14,408,798...14,419,383
G
DDX6
DEAD-box helicase 6
decreases expression
ISO
Cephaloridine results in decreased expression of DDX6 mRNA
CTD
PMID:18500788
NCBI chr11:118,747,763...118,791,744
Ensembl chr11:118,747,763...118,791,164
G
DECR2
2,4-dienoyl-CoA reductase 2
decreases expression
ISO
Cephaloridine results in decreased expression of DECR2 mRNA
CTD
PMID:18500788
NCBI chr16:401,885...412,482
Ensembl chr16:401,858...412,487
G
DLGAP1
DLG associated protein 1
increases expression
ISO
Cephaloridine results in increased expression of DLGAP1 mRNA
CTD
PMID:18500788
NCBI chr18:3,496,032...4,455,307
Ensembl chr18:3,496,032...4,455,307
G
DNAH7
dynein axonemal heavy chain 7
decreases expression
ISO
Cephaloridine results in decreased expression of DNAH7 mRNA
CTD
PMID:18500788
NCBI chr 2:195,737,703...196,068,837
Ensembl chr 2:195,737,703...196,068,837
G
DNAH9
dynein axonemal heavy chain 9
decreases expression
ISO
Cephaloridine results in decreased expression of DNAH9 mRNA
CTD
PMID:18500788
NCBI chr17:11,598,470...11,969,748
Ensembl chr17:11,598,470...11,969,748
G
DNASE1L3
deoxyribonuclease 1L3
increases expression
ISO
Cephaloridine results in increased expression of DNASE1L3 mRNA
CTD
PMID:18500788
NCBI chr 3:58,192,257...58,210,972
Ensembl chr 3:58,192,257...58,214,697
G
DNPH1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
ISO
Cephaloridine results in increased expression of DNPH1 mRNA
CTD
PMID:18500788
NCBI chr 6:43,225,629...43,229,481
Ensembl chr 6:43,225,629...43,229,481
G
DONSON
DNA replication fork stabilization factor DONSON
increases expression
ISO
Cephaloridine results in increased expression of DONSON mRNA
CTD
PMID:18500788
NCBI chr21:33,577,551...33,588,684
Ensembl chr21:33,559,542...33,588,706
G
DPF1
double PHD fingers 1
increases expression
ISO
Cephaloridine results in increased expression of DPF1 mRNA
CTD
PMID:18500788
NCBI chr19:38,211,006...38,229,695
Ensembl chr19:38,211,006...38,229,714
G
DSCC1
DNA replication and sister chromatid cohesion 1
increases expression
ISO
Cephaloridine results in increased expression of DSCC1 mRNA
CTD
PMID:18500788
NCBI chr 8:119,833,976...119,855,894
Ensembl chr 8:119,833,976...119,855,894
G
DSG2
desmoglein 2
increases expression
ISO
Cephaloridine results in increased expression of DSG2 mRNA
CTD
PMID:18500788
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,498,177...31,549,008
G
DTX4
deltex E3 ubiquitin ligase 4
increases expression
ISO
Cephaloridine results in increased expression of DTX4 mRNA
CTD
PMID:18500788
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
G
DUSP6
dual specificity phosphatase 6
affects expression
ISO
Cephaloridine affects the expression of DUSP6 mRNA
CTD
PMID:18172885
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DUSP7
dual specificity phosphatase 7
decreases expression
ISO
Cephaloridine results in decreased expression of DUSP7 mRNA
CTD
PMID:18500788
NCBI chr 3:52,048,919...52,056,571
Ensembl chr 3:52,048,919...52,056,571
G
DUSP9
dual specificity phosphatase 9
increases expression
ISO
Cephaloridine results in increased expression of DUSP9 mRNA
CTD
PMID:18500788
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
G
E2F8
E2F transcription factor 8
increases expression
ISO
Cephaloridine results in increased expression of E2F8 mRNA
CTD
PMID:18500788
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
G
EDRF1
erythroid differentiation regulatory factor 1
decreases expression
ISO
Cephaloridine results in decreased expression of EDRF1 mRNA
CTD
PMID:18500788
NCBI chr10:125,719,709...125,764,139
Ensembl chr10:125,719,515...125,764,143
G
EEF2
eukaryotic translation elongation factor 2
increases expression
ISO
Cephaloridine results in increased expression of EEF2 mRNA
CTD
PMID:18172885
NCBI chr19:3,976,056...3,985,463
Ensembl chr19:3,976,056...3,985,463
G
EGR1
early growth response 1
decreases expression
ISO
Cephaloridine results in decreased expression of EGR1 mRNA
CTD
PMID:18500788
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR2
early growth response 2
decreases expression
ISO
Cephaloridine results in decreased expression of EGR2 mRNA
CTD
PMID:18500788
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
G
EIF4H
eukaryotic translation initiation factor 4H
increases expression
ISO
Cephaloridine results in increased expression of EIF4H mRNA
CTD
PMID:18172885
NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122
G
ELF3
E74 like ETS transcription factor 3
increases expression
ISO
Cephaloridine results in increased expression of ELF3 mRNA
CTD
PMID:18500788
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
G
EMB
embigin
increases expression
ISO
Cephaloridine results in increased expression of EMB mRNA
CTD
PMID:18500788
NCBI chr 5:50,396,192...50,443,345
Ensembl chr 5:50,396,192...50,443,248
G
EME1
essential meiotic structure-specific endonuclease 1
decreases expression
ISO
Cephaloridine results in decreased expression of EME1 mRNA
CTD
PMID:18500788
NCBI chr17:50,373,229...50,381,483
Ensembl chr17:50,373,220...50,381,483
G
ENC1
ectodermal-neural cortex 1
increases expression
ISO
Cephaloridine results in increased expression of ENC1 mRNA
CTD
PMID:18500788
NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424
G
ENO2
enolase 2
increases expression
ISO
Cephaloridine results in increased expression of ENO2 mRNA
CTD
PMID:18500788
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
ENTREP1
endosomal transmembrane epsin interactor 1
increases expression
ISO
Cephaloridine results in increased expression of ENTREP1 mRNA
CTD
PMID:18500788
NCBI chr 9:69,324,567...69,392,456
Ensembl chr 9:69,324,567...69,392,558
G
ESPL1
extra spindle pole bodies like 1, separase
decreases expression
ISO
Cephaloridine results in decreased expression of ESPL1 mRNA
CTD
PMID:18500788
NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
G
EXO1
exonuclease 1
increases expression
ISO
Cephaloridine results in increased expression of EXO1 mRNA
CTD
PMID:18500788
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
G
F13B
coagulation factor XIII B chain
decreases expression
ISO
Cephaloridine results in decreased expression of F13B mRNA
CTD
PMID:18500788
NCBI chr 1:197,038,741...197,067,260
Ensembl chr 1:197,038,741...197,067,260
G
FAM111A
FAM111 trypsin like peptidase A
decreases expression
ISO
Cephaloridine results in decreased expression of FAM111A mRNA
CTD
PMID:18500788
NCBI chr11:59,142,856...59,155,039
Ensembl chr11:59,142,748...59,155,039
G
FANCD2
FA complementation group D2
increases expression
ISO
Cephaloridine results in increased expression of FANCD2 mRNA
CTD
PMID:18500788
NCBI chr 3:10,026,437...10,101,932
Ensembl chr 3:10,026,370...10,101,932
G
FBLN1
fibulin 1
increases expression
ISO
Cephaloridine results in increased expression of FBLN1 mRNA
CTD
PMID:18500788
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBP2
fructose-bisphosphatase 2
increases expression
ISO
Cephaloridine results in increased expression of FBP2 mRNA
CTD
PMID:18500788
NCBI chr 9:94,558,720...94,593,824
Ensembl chr 9:94,558,720...94,593,824
G
FBXO5
F-box protein 5
increases expression
ISO
Cephaloridine results in increased expression of FBXO5 mRNA
CTD
PMID:18500788
NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579
G
FCGR2A
Fc gamma receptor IIa
increases expression
ISO
Cephaloridine results in increased expression of FCGR2A mRNA
CTD
PMID:18500788
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR2B
Fc gamma receptor IIb
increases expression
ISO
Cephaloridine results in increased expression of FCGR2B mRNA
CTD
PMID:18500788
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
G
FCGR3A
Fc gamma receptor IIIa
increases expression
ISO
Cephaloridine results in increased expression of FCGR3A mRNA
CTD
PMID:18500788
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
FCN1
ficolin 1
increases expression
ISO
Cephaloridine results in increased expression of FCNB mRNA
CTD
PMID:18500788
NCBI chr 9:134,903,232...134,917,912
Ensembl chr 9:134,903,232...134,917,912
G
FEN1
flap structure-specific endonuclease 1
increases expression
ISO
Cephaloridine results in increased expression of FEN1 mRNA
CTD
PMID:18500788
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
G
FGB
fibrinogen beta chain
increases expression
ISO
Cephaloridine results in increased expression of FGB mRNA
CTD
PMID:18500788
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGF17
fibroblast growth factor 17
increases expression
ISO
Cephaloridine results in increased expression of FGF17 mRNA
CTD
PMID:18500788
NCBI chr 8:22,039,672...22,048,809
Ensembl chr 8:22,042,398...22,048,809
G
FGL2
fibrinogen like 2
increases expression
ISO
Cephaloridine results in increased expression of FGL2 mRNA
CTD
PMID:18500788
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
G
FHDC1
FH2 domain containing 1
increases expression
ISO
Cephaloridine results in increased expression of FHDC1 mRNA
CTD
PMID:18500788
NCBI chr 4:152,911,339...152,979,671
Ensembl chr 4:152,936,323...152,979,671
G
FILIP1
filamin A interacting protein 1
decreases expression
ISO
Cephaloridine results in decreased expression of FILIP1 mRNA
CTD
PMID:18500788
NCBI chr 6:75,291,859...75,493,800
Ensembl chr 6:75,291,859...75,493,800
G
FOLH1
folate hydrolase 1
decreases expression
ISO
Cephaloridine results in decreased expression of FOLH1 mRNA
CTD
PMID:18500788
NCBI chr11:49,145,092...49,208,602
Ensembl chr11:49,145,092...49,208,638
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Cephaloridine results in decreased expression of FOS mRNA
CTD
PMID:18500788
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOXE1
forkhead box E1
decreases expression
ISO
Cephaloridine results in decreased expression of FOXE1 mRNA
CTD
PMID:18500788
NCBI chr 9:97,853,226...97,856,717
Ensembl chr 9:97,853,226...97,856,717
G
FOXQ1
forkhead box Q1
increases expression
ISO
Cephaloridine results in increased expression of FOXQ1 mRNA
CTD
PMID:18500788
NCBI chr 6:1,312,098...1,314,758
Ensembl chr 6:1,312,098...1,314,758
G
FYCO1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
Cephaloridine results in decreased expression of FYCO1 mRNA
CTD
PMID:18500788
NCBI chr 3:45,917,903...45,995,824
Ensembl chr 3:45,917,903...45,995,824
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
Cephaloridine results in decreased expression of G6PC1 mRNA
CTD
PMID:18500788
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
ISO
Cephaloridine results in increased expression of G6PD mRNA
CTD
PMID:18500788
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
ISO
Cephaloridine results in increased expression of GADD45A mRNA
CTD
PMID:18172885
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GALNT13
polypeptide N-acetylgalactosaminyltransferase 13
increases expression
ISO
Cephaloridine results in increased expression of GALNT13 mRNA
CTD
PMID:18500788
NCBI chr 2:153,068,293...154,456,574
Ensembl chr 2:153,871,922...154,453,979 Ensembl chr 2:153,871,922...154,453,979
G
GANC
glucosidase alpha, neutral C
decreases expression
ISO
Cephaloridine results in decreased expression of GANC mRNA
CTD
PMID:18500788
NCBI chr15:42,273,201...42,353,666
Ensembl chr15:42,273,201...42,353,666
G
GARIN4
golgi associated RAB2 interactor family member 4
increases expression
ISO
Cephaloridine results in increased expression of GARIN4 mRNA
CTD
PMID:18500788
NCBI chr 1:212,624,474...212,626,775
Ensembl chr 1:212,624,474...212,626,775
G
GBA3
glucosylceramidase beta 3 (gene/pseudogene)
decreases expression
ISO
Cephaloridine results in decreased expression of GBA3 mRNA
CTD
PMID:18500788
NCBI chr 4:22,692,937...22,819,569
Ensembl chr 4:22,692,914...22,819,575
G
GDA
guanine deaminase
increases expression
ISO
Cephaloridine results in increased expression of GDA mRNA
CTD
PMID:18500788
NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
G
GDF15
growth differentiation factor 15
decreases expression
ISO
Cephaloridine results in decreased expression of GDF15 mRNA
CTD
PMID:18500788
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GFRA2
GDNF family receptor alpha 2
decreases expression
ISO
Cephaloridine results in decreased expression of GFRA2 mRNA
CTD
PMID:18500788
NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357
G
GINS2
GINS complex subunit 2
increases expression
ISO
Cephaloridine results in increased expression of GINS2 mRNA
CTD
PMID:18500788
NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
G
GINS4
GINS complex subunit 4
increases expression
ISO
Cephaloridine results in increased expression of GINS4 mRNA
CTD
PMID:18500788
NCBI chr 8:41,529,261...41,545,030
Ensembl chr 8:41,529,218...41,545,030
G
GMNN
geminin DNA replication inhibitor
increases expression
ISO
Cephaloridine results in increased expression of GMNN mRNA
CTD
PMID:18500788
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GNA14
G protein subunit alpha 14
increases expression
ISO
Cephaloridine results in increased expression of GNA14 mRNA
CTD
PMID:18500788
NCBI chr 9:77,423,079...77,648,322
Ensembl chr 9:77,423,079...77,648,322
G
GPNMB
glycoprotein nmb
increases expression
ISO
Cephaloridine results in increased expression of GPNMB mRNA
CTD
PMID:18500788
NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
G
GPR135
G protein-coupled receptor 135
decreases expression
ISO
Cephaloridine results in decreased expression of GPR135 mRNA
CTD
PMID:18500788
NCBI chr14:59,452,783...59,465,380
Ensembl chr14:59,429,022...59,465,380
G
GPR19
G protein-coupled receptor 19
increases expression
ISO
Cephaloridine results in increased expression of GPR19 mRNA
CTD
PMID:18500788
NCBI chr12:12,660,890...12,717,246
Ensembl chr12:12,660,890...12,696,207
G
GPX2
glutathione peroxidase 2
increases expression
ISO
Cephaloridine results in increased expression of GPX2 mRNA
CTD
PMID:18500788
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GRIA3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
ISO
Cephaloridine results in decreased expression of GRIA3 mRNA
CTD
PMID:18500788
NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915
G
GSR
glutathione-disulfide reductase
increases expression
ISO
Cephaloridine results in increased expression of GSR mRNA
CTD
PMID:18172885
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA2
glutathione S-transferase alpha 2
increases expression
ISO
Cephaloridine results in increased expression of GSTA2 mRNA
CTD
PMID:18172885
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTA5
glutathione S-transferase alpha 5
increases expression
ISO
Cephaloridine results in increased expression of GSTA5 mRNA
CTD
PMID:18172885
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
G
GSTM1
glutathione S-transferase mu 1
increases expression
ISO
Cephaloridine results in increased expression of GSTM1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTP1
glutathione S-transferase pi 1
increases expression
ISO
Cephaloridine results in increased expression of GSTP1 mRNA
CTD
PMID:18500788
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GXYLT1
glucoside xylosyltransferase 1
decreases expression
ISO
Cephaloridine results in decreased expression of GXYLT1 mRNA
CTD
PMID:18500788
NCBI chr12:42,081,845...42,144,874
Ensembl chr12:42,081,845...42,144,874
G
H1-1
H1.1 linker histone, cluster member
increases expression
ISO
Cephaloridine results in increased expression of H1F1 mRNA
CTD
PMID:18500788
NCBI chr 6:26,017,032...26,017,787
Ensembl chr 6:26,017,032...26,017,787
G
HADH
hydroxyacyl-CoA dehydrogenase
decreases expression
ISO
Cephaloridine results in decreased expression of HADH mRNA
CTD
PMID:18500788
NCBI chr 4:107,989,889...108,035,171
Ensembl chr 4:107,989,714...108,035,241
G
HAUS8
HAUS augmin like complex subunit 8
increases expression
ISO
Cephaloridine results in increased expression of HAUS8 mRNA
CTD
PMID:18500788
NCBI chr19:17,049,729...17,075,533
Ensembl chr19:17,049,729...17,075,625
G
HAVCR1
hepatitis A virus cellular receptor 1
increases expression
ISO
Cephaloridine results in increased expression of HAVCR1 mRNA
CTD
PMID:18500788 PMID:20305092
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HCK
HCK proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Cephaloridine results in increased expression of HCK mRNA
CTD
PMID:18500788
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
G
HEBP1
heme binding protein 1
increases expression
ISO
Cephaloridine results in increased expression of HEBP1 mRNA
CTD
PMID:18500788
NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265
G
HEBP2
heme binding protein 2
increases expression
ISO
Cephaloridine results in increased expression of HEBP2 mRNA
CTD
PMID:18500788
NCBI chr 6:138,403,531...138,422,197
Ensembl chr 6:138,403,531...138,422,197
G
HELLS
helicase, lymphoid specific
increases expression
ISO
Cephaloridine results in increased expression of HELLS mRNA
CTD
PMID:18500788
NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905
G
HEPACAM2
HEPACAM family member 2
increases expression
ISO
Cephaloridine results in increased expression of HEPACAM2 mRNA
CTD
PMID:18500788
NCBI chr 7:93,188,534...93,232,285
Ensembl chr 7:93,188,534...93,226,469
G
HJV
hemojuvelin BMP co-receptor
decreases expression
ISO
Cephaloridine results in decreased expression of HJV mRNA
CTD
PMID:18500788
NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
G
HLX
H2.0 like homeobox
decreases expression
ISO
Cephaloridine results in decreased expression of HLX mRNA
CTD
PMID:18500788
NCBI chr 1:220,879,443...220,885,059
Ensembl chr 1:220,879,431...220,885,059
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
Cephaloridine results in decreased expression of HMGCS2 mRNA
CTD
PMID:18500788
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
G
HMOX1
heme oxygenase 1
increases expression
ISO
Cephaloridine results in increased expression of HMOX1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HMX3
H6 family homeobox 3
increases expression
ISO
Cephaloridine results in increased expression of HMX3 mRNA
CTD
PMID:18500788
NCBI chr10:123,135,970...123,139,423
Ensembl chr10:123,135,970...123,139,423
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
Cephaloridine results in increased expression of HNRNPA1 mRNA
CTD
PMID:18500788
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
HRG
histidine rich glycoprotein
decreases expression
ISO
Cephaloridine results in decreased expression of HRG mRNA
CTD
PMID:18500788
NCBI chr 3:186,666,014...186,678,234
Ensembl chr 3:186,660,216...186,678,234
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
decreases expression
ISO
Cephaloridine results in decreased expression of HSD17B2 mRNA
CTD
PMID:18500788
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
increases expression
ISO
Cephaloridine results in increased expression of HSD3B1 mRNA
CTD
PMID:18500788
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
Cephaloridine results in increased expression of HSP90AA1 mRNA
CTD
PMID:18500788
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Cephaloridine results in increased expression of HSPA1A mRNA
CTD
PMID:18500788
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Cephaloridine results in increased expression of HSPA1B mRNA
CTD
PMID:18500788
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPH1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
Cephaloridine results in increased expression of HSPH1 mRNA
CTD
PMID:18500788
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
G
HTATIP2
HIV-1 Tat interactive protein 2
increases expression
ISO
Cephaloridine results in increased expression of HTATIP2 mRNA
CTD
PMID:18500788
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
G
ICAM1
intercellular adhesion molecule 1
increases expression
ISO
Cephaloridine results in increased expression of ICAM1 mRNA
CTD
PMID:18500788
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IER3
immediate early response 3
decreases expression
ISO
Cephaloridine results in decreased expression of IER3 mRNA
CTD
PMID:18500788
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFITM10
interferon induced transmembrane protein 10
increases expression
ISO
Cephaloridine results in increased expression of IFITM10 mRNA
CTD
PMID:18500788
NCBI chr11:1,732,406...1,750,595
Ensembl chr11:1,732,406...1,750,595
G
IL18
interleukin 18
increases expression
ISO
Cephaloridine results in increased expression of IL18 mRNA
CTD
PMID:18500788
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
decreases expression
ISO
Cephaloridine results in decreased expression of IL1B mRNA
CTD
PMID:18500788
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL20RA
interleukin 20 receptor subunit alpha
decreases expression
ISO
Cephaloridine results in decreased expression of IL20RA mRNA
CTD
PMID:18500788
NCBI chr 6:136,999,971...137,044,965
Ensembl chr 6:136,999,971...137,045,180
G
INHBB
inhibin subunit beta B
decreases expression
ISO
Cephaloridine results in decreased expression of INHBB mRNA
CTD
PMID:18500788
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
ITPKA
inositol-trisphosphate 3-kinase A
increases expression
ISO
Cephaloridine results in increased expression of ITPKA mRNA
CTD
PMID:18500788
NCBI chr15:41,493,874...41,503,551
Ensembl chr15:41,493,393...41,503,551
G
ITPKB
inositol-trisphosphate 3-kinase B
increases expression
ISO
Cephaloridine results in increased expression of ITPKB mRNA
CTD
PMID:18500788
NCBI chr 1:226,631,690...226,739,282
Ensembl chr 1:226,631,690...226,739,323
G
JADE2
jade family PHD finger 2
decreases expression
ISO
Cephaloridine results in decreased expression of JADE2 mRNA
CTD
PMID:18500788
NCBI chr 5:134,523,952...134,583,227
Ensembl chr 5:134,524,312...134,583,230
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Cephaloridine results in increased expression of JUN mRNA
CTD
PMID:18172885
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
ISO
Cephaloridine results in decreased expression of JUNB mRNA Cephaloridine results in increased expression of JUNB mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
KBTBD11
kelch repeat and BTB domain containing 11
decreases expression
ISO
Cephaloridine results in decreased expression of KBTBD11 mRNA
CTD
PMID:18500788
NCBI chr 8:1,973,677...2,006,936
Ensembl chr 8:1,973,677...2,006,936
G
KCNH1
potassium voltage-gated channel subfamily H member 1
increases expression
ISO
Cephaloridine results in increased expression of KCNH1 mRNA
CTD
PMID:18500788
NCBI chr 1:210,678,314...211,134,148
Ensembl chr 1:210,676,823...211,134,165
G
KCNJ15
potassium inwardly rectifying channel subfamily J member 15
decreases expression
ISO
Cephaloridine results in decreased expression of KCNJ15 mRNA
CTD
PMID:18500788
NCBI chr21:38,229,926...38,307,357
Ensembl chr21:38,155,549...38,307,357
G
KCTD1
potassium channel tetramerization domain containing 1
increases expression
ISO
Cephaloridine results in increased expression of KCTD1 mRNA
CTD
PMID:18500788
NCBI chr18:26,454,910...26,657,473
Ensembl chr18:26,454,910...26,657,401
G
KGD4
alpha-ketoglutarate dehydrogenase subunit 4
increases expression
ISO
Cephaloridine results in increased expression of KGD4 mRNA
CTD
PMID:18500788
NCBI chr 5:69,217,760...69,230,158
Ensembl chr 5:69,217,760...69,230,158
G
KIF18A
kinesin family member 18A
decreases expression
ISO
Cephaloridine results in decreased expression of KIF18A mRNA
CTD
PMID:18500788
NCBI chr11:28,020,619...28,108,156
Ensembl chr11:28,020,619...28,108,156
G
KIF2C
kinesin family member 2C
decreases expression
ISO
Cephaloridine results in decreased expression of KIF2C mRNA
CTD
PMID:18500788
NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
G
KLF7
KLF transcription factor 7
decreases expression
ISO
Cephaloridine results in decreased expression of KLF7 mRNA
CTD
PMID:18500788
NCBI chr 2:207,074,137...207,173,851
Ensembl chr 2:207,074,137...207,173,856
G
KLHL25
kelch like family member 25
decreases expression
ISO
Cephaloridine results in decreased expression of KLHL25 mRNA
CTD
PMID:18500788
NCBI chr15:85,759,326...85,794,925
Ensembl chr15:85,759,326...85,794,925
G
KNSTRN
kinetochore localized astrin (SPAG5) binding protein
decreases expression
ISO
Cephaloridine results in decreased expression of KNSTRN mRNA
CTD
PMID:18500788
NCBI chr15:40,382,721...40,394,288
Ensembl chr15:40,382,721...40,394,288
G
KNTC1
kinetochore associated 1
increases expression
ISO
Cephaloridine results in increased expression of KNTC1 mRNA
CTD
PMID:18500788
NCBI chr12:122,527,249...122,626,396
Ensembl chr12:122,527,246...122,626,396
G
LAMA2
laminin subunit alpha 2
decreases expression
ISO
Cephaloridine results in decreased expression of LAMA2 mRNA
CTD
PMID:18500788
NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566
G
LAMB3
laminin subunit beta 3
increases expression
ISO
Cephaloridine results in increased expression of LAMB3 mRNA
CTD
PMID:18500788
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
G
LARS1
leucyl-tRNA synthetase 1
decreases expression
ISO
Cephaloridine results in decreased expression of LARS1 mRNA
CTD
PMID:18500788
NCBI chr 5:146,113,034...146,182,650
Ensembl chr 5:146,110,566...146,182,696
G
LCOR
ligand dependent nuclear receptor corepressor
decreases expression
ISO
Cephaloridine results in decreased expression of LCOR mRNA
CTD
PMID:18500788
NCBI chr10:96,832,298...96,995,956
Ensembl chr10:96,832,254...96,995,956
G
LECT2
leukocyte cell derived chemotaxin 2
decreases expression
ISO
Cephaloridine results in decreased expression of LECT2 mRNA
CTD
PMID:18500788
NCBI chr 5:135,946,904...135,954,983
Ensembl chr 5:135,922,279...135,954,983
G
LGALS2
galectin 2
increases expression
ISO
Cephaloridine results in increased expression of LGALS2 mRNA
CTD
PMID:18500788
NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616
G
LGALS3
galectin 3
increases expression
ISO
Cephaloridine results in increased expression of LGALS3 mRNA
CTD
PMID:18500788
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LHX3
LIM homeobox 3
decreases expression
ISO
Cephaloridine results in decreased expression of LHX3 mRNA
CTD
PMID:18500788
NCBI chr 9:136,196,250...136,205,128
Ensembl chr 9:136,196,250...136,205,128
G
LIG1
DNA ligase 1
increases expression
ISO
Cephaloridine results in increased expression of LIG1 mRNA
CTD
PMID:18500788
NCBI chr19:48,115,445...48,170,344
Ensembl chr19:48,115,445...48,170,603
G
LMNB1
lamin B1
decreases expression
ISO
Cephaloridine results in decreased expression of LMNB1 mRNA
CTD
PMID:18500788
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
G
LRATD1
LRAT domain containing 1
increases expression
ISO
Cephaloridine results in increased expression of LRATD1 mRNA
CTD
PMID:18500788
NCBI chr 2:14,632,717...14,651,916
Ensembl chr 2:14,632,700...14,650,814
G
LRRN3
leucine rich repeat neuronal 3
decreases expression
ISO
Cephaloridine results in decreased expression of LRRN3 mRNA
CTD
PMID:18500788
NCBI chr 7:111,091,127...111,125,454
Ensembl chr 7:111,091,006...111,125,454
G
MAF
MAF bZIP transcription factor
decreases expression
ISO
Cephaloridine results in decreased expression of MAF mRNA
CTD
PMID:18500788
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
G
MAP3K1
mitogen-activated protein kinase kinase kinase 1
increases expression
ISO
Cephaloridine results in increased expression of MAP3K1 mRNA
CTD
PMID:18172885
NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152
G
MAP3K12
mitogen-activated protein kinase kinase kinase 12
decreases expression
ISO
Cephaloridine results in decreased expression of MAP3K12 mRNA
CTD
PMID:18172885
NCBI chr12:53,479,669...53,501,539
Ensembl chr12:53,479,669...53,500,063
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation increases activity
ISO
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein] Cephaloridine results in increased activity of MAPK1 protein
CTD
PMID:16154539 PMID:16272694
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
increases activity multiple interactions increases phosphorylation
ISO
Cephaloridine results in increased activity of MAPK3 protein Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]
CTD
PMID:16154539 PMID:16272694
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8IP3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
ISO
Cephaloridine results in increased expression of MAPK8IP3 mRNA
CTD
PMID:18500788
NCBI chr16:1,706,195...1,770,351
Ensembl chr16:1,706,166...1,770,351
G
MASP2
MBL associated serine protease 2
increases expression
ISO
Cephaloridine results in increased expression of MASP2 mRNA
CTD
PMID:18500788
NCBI chr 1:11,026,523...11,047,239
Ensembl chr 1:11,022,009...11,047,239
G
MCM2
minichromosome maintenance complex component 2
increases expression
ISO
Cephaloridine results in increased expression of MCM2 mRNA
CTD
PMID:18500788
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
G
MCM3
minichromosome maintenance complex component 3
increases expression
ISO
Cephaloridine results in increased expression of MCM3 mRNA
CTD
PMID:18500788
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
G
MCM5
minichromosome maintenance complex component 5
increases expression
ISO
Cephaloridine results in increased expression of MCM5 mRNA
CTD
PMID:18500788
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
G
MCM6
minichromosome maintenance complex component 6
increases expression
ISO
Cephaloridine results in increased expression of MCM6 mRNA
CTD
PMID:18500788
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
G
MCM7
minichromosome maintenance complex component 7
increases expression
ISO
Cephaloridine results in increased expression of MCM7 mRNA
CTD
PMID:18500788
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
G
MCM8
minichromosome maintenance 8 homologous recombination repair factor
increases expression
ISO
Cephaloridine results in increased expression of MCM8 mRNA
CTD
PMID:18500788
NCBI chr20:5,950,652...5,998,977
Ensembl chr20:5,950,652...5,998,977
G
MESP1
mesoderm posterior bHLH transcription factor 1
decreases expression
ISO
Cephaloridine results in decreased expression of MESP1 mRNA
CTD
PMID:18500788
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
G
MET
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Cephaloridine results in increased expression of MET mRNA
CTD
PMID:18172885
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MGLL
monoglyceride lipase
decreases expression
ISO
Cephaloridine results in decreased expression of MGLL mRNA
CTD
PMID:18500788
NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190
G
MKI67
marker of proliferation Ki-67
decreases expression
ISO
Cephaloridine results in decreased expression of MKI67 mRNA
CTD
PMID:18500788
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MMP12
matrix metallopeptidase 12
increases expression
ISO
Cephaloridine results in increased expression of MMP12 mRNA
CTD
PMID:18500788
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP16
matrix metallopeptidase 16
increases expression
ISO
Cephaloridine results in increased expression of MMP16 mRNA
CTD
PMID:18500788
NCBI chr 8:88,032,011...88,327,483
Ensembl chr 8:88,032,011...88,328,025
G
MND1
meiotic nuclear divisions 1
increases expression
ISO
Cephaloridine results in increased expression of MND1 mRNA
CTD
PMID:18500788
NCBI chr 4:153,344,649...153,415,118
Ensembl chr 4:153,344,649...153,415,118
G
MNS1
meiosis specific nuclear structural 1
decreases expression
ISO
Cephaloridine results in decreased expression of MNS1 mRNA
CTD
PMID:18500788
NCBI chr15:56,428,724...56,465,137
Ensembl chr15:56,421,544...56,465,137
G
MPST
mercaptopyruvate sulfurtransferase
decreases expression
ISO
Cephaloridine results in decreased expression of MPST mRNA
CTD
PMID:18500788
NCBI chr22:37,019,742...37,029,815
Ensembl chr22:37,019,635...37,029,821
G
MPV17L
MPV17 mitochondrial inner membrane protein like
decreases expression
ISO
Cephaloridine results in decreased expression of MPV17L mRNA
CTD
PMID:18500788
NCBI chr16:15,395,754...15,413,271
Ensembl chr16:15,395,754...15,413,271
G
MT1A
metallothionein 1A
decreases expression
ISO
Cephaloridine results in decreased expression of MT1A mRNA
CTD
PMID:18172885
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
G
MTHFD1L
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like
increases expression
ISO
Cephaloridine results in increased expression of MTHFD1L mRNA
CTD
PMID:18500788
NCBI chr 6:150,865,702...151,101,887
Ensembl chr 6:150,865,679...151,101,887
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
ISO
Cephaloridine results in increased expression of MTHFD2 mRNA
CTD
PMID:18500788
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
G
MYOM3
myomesin 3
increases expression
ISO
Cephaloridine results in increased expression of MYOM3 mRNA
CTD
PMID:18500788
NCBI chr 1:24,056,041...24,112,135
Ensembl chr 1:24,056,035...24,112,135
G
NCOR2
nuclear receptor corepressor 2
decreases expression
ISO
Cephaloridine results in decreased expression of NCOR2 mRNA
CTD
PMID:18500788
NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,612
G
NEK6
NIMA related kinase 6
increases expression
ISO
Cephaloridine results in increased expression of NEK6 mRNA
CTD
PMID:18500788
NCBI chr 9:124,257,606...124,353,307
Ensembl chr 9:124,257,606...124,353,307
G
NFIL3
nuclear factor, interleukin 3 regulated
increases expression
ISO
Cephaloridine results in increased expression of NFIL3 mRNA
CTD
PMID:18500788
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
G
NFKBIA
NFKB inhibitor alpha
decreases expression
ISO
Cephaloridine results in decreased expression of NFKBIA mRNA
CTD
PMID:18172885
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIZ
NFKB inhibitor zeta
decreases expression
ISO
Cephaloridine results in decreased expression of NFKBIZ mRNA
CTD
PMID:18500788
NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022
G
NGFR
nerve growth factor receptor
increases expression
ISO
Cephaloridine results in increased expression of NGFR mRNA
CTD
PMID:18500788
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NHP2
NHP2 ribonucleoprotein
increases expression
ISO
Cephaloridine results in increased expression of NHP2 mRNA
CTD
PMID:18500788
NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894
G
NINJ2
ninjurin 2
increases expression
ISO
Cephaloridine results in increased expression of NINJ2 mRNA
CTD
PMID:18500788
NCBI chr12:564,296...663,445
Ensembl chr12:564,296...663,589
G
NIPSNAP3A
nipsnap homolog 3A
increases expression
ISO
Cephaloridine results in increased expression of NIPSNAP3B mRNA
CTD
PMID:18500788
NCBI chr 9:104,747,683...104,760,120
Ensembl chr 9:104,747,683...104,760,120
G
NME4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
ISO
Cephaloridine results in decreased expression of NME4 mRNA
CTD
PMID:18500788
NCBI chr16:396,729...400,754
Ensembl chr16:396,725...410,367
G
NOP56
NOP56 ribonucleoprotein
increases expression
ISO
Cephaloridine results in increased expression of NOP56 mRNA
CTD
PMID:18500788
NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Cephaloridine results in increased expression of NQO1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1D1
nuclear receptor subfamily 1 group D member 1
increases expression
ISO
Cephaloridine results in increased expression of NR1D1 mRNA
CTD
PMID:18500788
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
G
NRM
nurim
increases expression
ISO
Cephaloridine results in increased expression of NRM mRNA
CTD
PMID:18500788
NCBI chr 6:30,688,049...30,691,420
Ensembl chr 6:30,688,047...30,691,420
G
NUDT11
nudix hydrolase 11
increases expression
ISO
Cephaloridine results in increased expression of NUDT11 mRNA
CTD
PMID:18500788
NCBI chr X:51,490,011...51,496,592
Ensembl chr X:51,490,011...51,496,592
G
NUDT4
nudix hydrolase 4
increases expression
ISO
Cephaloridine results in increased expression of NUDT10 mRNA
CTD
PMID:18500788
NCBI chr12:93,377,925...93,408,146
Ensembl chr12:93,377,883...93,408,146
G
OPRL1
opioid related nociceptin receptor 1
increases expression
ISO
Cephaloridine results in increased expression of OPRL1 mRNA
CTD
PMID:18500788
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
OR2W6P
olfactory receptor family 2 subfamily W member 6 pseudogene
increases expression
ISO
Cephaloridine results in increased expression of OR2W6 mRNA
CTD
PMID:18500788
NCBI chr 6:27,937,404...27,938,401
Ensembl chr 6:27,937,465...27,938,403
G
OR52B2
olfactory receptor family 52 subfamily B member 2
increases expression
ISO
Cephaloridine results in increased expression of OR52B2 mRNA
CTD
PMID:18500788
NCBI chr11:6,169,355...6,170,326
Ensembl chr11:6,169,355...6,170,326
G
OR52K1
olfactory receptor family 52 subfamily K member 1
decreases expression
ISO
Cephaloridine results in decreased expression of OR52K1 mRNA
CTD
PMID:18500788
NCBI chr11:4,482,646...4,493,497
Ensembl chr11:4,482,646...4,493,497
G
ORC6
origin recognition complex subunit 6
increases expression
ISO
Cephaloridine results in increased expression of ORC6 mRNA
CTD
PMID:18500788
NCBI chr16:46,689,659...46,698,394
Ensembl chr16:46,689,643...46,698,394
G
OSBPL8
oxysterol binding protein like 8
decreases expression
ISO
Cephaloridine results in decreased expression of OSBPL8 mRNA
CTD
PMID:18500788
NCBI chr12:76,351,797...76,559,771
Ensembl chr12:76,351,797...76,559,809
G
OSMR
oncostatin M receptor
increases expression
ISO
Cephaloridine results in increased expression of OSMR mRNA
CTD
PMID:18500788
NCBI chr 5:38,846,012...38,945,579
Ensembl chr 5:38,845,858...38,945,596
G
OXGR1
oxoglutarate receptor 1
increases expression
ISO
Cephaloridine results in increased expression of OXGR1 mRNA
CTD
PMID:18500788
NCBI chr13:96,985,713...96,994,730
Ensembl chr13:96,985,713...96,994,730
G
PADI6
peptidyl arginine deiminase 6
increases expression
ISO
Cephaloridine results in increased expression of PADI6 mRNA
CTD
PMID:18500788
NCBI chr 1:17,372,196...17,401,699
Ensembl chr 1:17,372,196...17,401,699
G
PALB2
partner and localizer of BRCA2
increases expression
ISO
Cephaloridine results in increased expression of PALB2 mRNA
CTD
PMID:18500788
NCBI chr16:23,603,165...23,641,310
Ensembl chr16:23,603,160...23,641,321
G
PASK
PAS domain containing serine/threonine kinase
increases expression
ISO
Cephaloridine results in increased expression of PASK mRNA
CTD
PMID:18500788
NCBI chr 2:241,106,099...241,150,347
Ensembl chr 2:241,106,099...241,150,264
G
PBK
PDZ binding kinase
decreases expression
ISO
Cephaloridine results in decreased expression of PBK mRNA
CTD
PMID:18500788
NCBI chr 8:27,809,624...27,837,817
Ensembl chr 8:27,809,624...27,838,082
G
PCDH7
protocadherin 7
decreases expression
ISO
Cephaloridine results in decreased expression of PCDH7 mRNA
CTD
PMID:18500788
NCBI chr 4:30,720,369...31,146,800
Ensembl chr 4:30,720,369...31,146,805
G
PCDH9
protocadherin 9
decreases expression
ISO
Cephaloridine results in decreased expression of PCDH9 mRNA
CTD
PMID:18500788
NCBI chr13:66,302,834...67,230,336
Ensembl chr13:66,302,834...67,230,445
G
PCK1
phosphoenolpyruvate carboxykinase 1
decreases expression
ISO
Cephaloridine results in decreased expression of PCK1 mRNA
CTD
PMID:18500788
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
G
PCLAF
PCNA clamp associated factor
increases expression
ISO
Cephaloridine results in increased expression of PCLAF mRNA
CTD
PMID:18500788
NCBI chr15:64,364,304...64,387,687
Ensembl chr15:64,364,304...64,387,687
G
PCNA
proliferating cell nuclear antigen
increases expression
ISO
Cephaloridine results in increased expression of PCNA mRNA
CTD
PMID:18500788
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDIA4
protein disulfide isomerase family A member 4
increases expression
ISO
Cephaloridine results in increased expression of PDIA4 mRNA
CTD
PMID:18172885
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
G
PFN3
profilin 3
decreases expression
ISO
Cephaloridine results in decreased expression of PFN3 mRNA
CTD
PMID:18500788
NCBI chr 5:177,400,109...177,400,661
Ensembl chr 5:177,400,109...177,400,661
G
PIPOX
pipecolic acid and sarcosine oxidase
increases expression
ISO
Cephaloridine results in increased expression of PIPOX mRNA
CTD
PMID:18500788
NCBI chr17:29,043,141...29,057,216
Ensembl chr17:28,950,513...29,057,216
G
PIR
pirin
increases expression
ISO
Cephaloridine results in increased expression of PIR mRNA
CTD
PMID:18500788
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PKHD1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
ISO
Cephaloridine results in decreased expression of PKHD1 mRNA
CTD
PMID:18500788
NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613
G
PKMYT1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
ISO
Cephaloridine results in increased expression of PKMYT1 mRNA
CTD
PMID:18500788
NCBI chr16:2,972,808...2,980,446
Ensembl chr16:2,968,024...2,980,479
G
PLA1A
phospholipase A1 member A
increases expression
ISO
Cephaloridine results in increased expression of PLA1A mRNA
CTD
PMID:18500788
NCBI chr 3:119,597,885...119,629,811
Ensembl chr 3:119,597,875...119,629,811
G
PLEK2
pleckstrin 2
increases expression
ISO
Cephaloridine results in increased expression of PLEK2 mRNA
CTD
PMID:18500788
NCBI chr14:67,386,984...67,412,165
Ensembl chr14:67,386,984...67,412,167
G
PLEKHA5
pleckstrin homology domain containing A5
decreases expression
ISO
Cephaloridine results in decreased expression of PLEKHA5 mRNA
CTD
PMID:18500788
NCBI chr12:19,129,733...19,376,400
Ensembl chr12:19,129,669...19,376,400
G
PLK1
polo like kinase 1
decreases expression
ISO
Cephaloridine results in decreased expression of PLK1 mRNA
CTD
PMID:18500788
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
G
POLA2
DNA polymerase alpha 2, accessory subunit
increases expression
ISO
Cephaloridine results in increased expression of POLA2 mRNA
CTD
PMID:18500788
NCBI chr11:65,261,962...65,305,985
Ensembl chr11:65,261,913...65,305,959
G
POLD1
DNA polymerase delta 1, catalytic subunit
increases expression
ISO
Cephaloridine results in increased expression of POLD1 mRNA
CTD
PMID:18500788
NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018
G
POLE
DNA polymerase epsilon, catalytic subunit
increases expression
ISO
Cephaloridine results in increased expression of POLE mRNA
CTD
PMID:18500788
NCBI chr12:132,623,762...132,687,342
Ensembl chr12:132,623,753...132,687,376
G
PPA1
inorganic pyrophosphatase 1
increases expression
ISO
Cephaloridine results in increased expression of PPA1 mRNA
CTD
PMID:18500788
NCBI chr10:70,202,835...70,233,429
Ensembl chr10:70,202,835...70,233,911
G
PPM1J
protein phosphatase, Mg2+/Mn2+ dependent 1J
increases expression
ISO
Cephaloridine results in increased expression of PPM1J mRNA
CTD
PMID:18500788
NCBI chr 1:112,709,998...112,715,332
Ensembl chr 1:112,709,994...112,715,332
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
decreases expression
ISO
Cephaloridine results in decreased expression of PPP1R15A mRNA
CTD
PMID:18500788
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
G
PRC1
protein regulator of cytokinesis 1
decreases expression
ISO
Cephaloridine results in decreased expression of PRC1 mRNA
CTD
PMID:18500788
NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629
G
PRIM1
DNA primase subunit 1
increases expression
ISO
Cephaloridine results in increased expression of PRIM1 mRNA
CTD
PMID:18500788
NCBI chr12:56,731,580...56,752,323
Ensembl chr12:56,730,438...56,752,374
G
PRKAR1B
protein kinase cAMP-dependent type I regulatory subunit beta
increases expression
ISO
Cephaloridine results in increased expression of PRKAR1B mRNA
CTD
PMID:18500788
NCBI chr 7:549,197...728,934
Ensembl chr 7:549,197...727,650
G
PRODH2
proline dehydrogenase 2
decreases expression
ISO
Cephaloridine results in decreased expression of PRODH2 mRNA
CTD
PMID:18500788
NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,988...35,813,299
G
PRRX1
paired related homeobox 1
decreases expression
ISO
Cephaloridine results in decreased expression of PRRX1 mRNA
CTD
PMID:18500788
NCBI chr 1:170,662,768...170,739,421
Ensembl chr 1:170,662,728...170,739,421
G
PRSS35
serine protease 35
decreases expression
ISO
Cephaloridine results in decreased expression of PRSS35 mRNA
CTD
PMID:18500788
NCBI chr 6:83,512,534...83,525,704
Ensembl chr 6:83,512,534...83,525,704
G
PSMB4
proteasome 20S subunit beta 4
increases expression
ISO
Cephaloridine results in increased expression of PSMB4 mRNA
CTD
PMID:18172885
NCBI chr 1:151,399,573...151,401,937
Ensembl chr 1:151,399,560...151,401,937
G
PTBP1
polypyrimidine tract binding protein 1
increases expression
ISO
Cephaloridine results in increased expression of PTBP1 mRNA
CTD
PMID:18172885
NCBI chr19:797,452...812,312
Ensembl chr19:797,075...812,327
G
PTGR1
prostaglandin reductase 1
increases expression
ISO
Cephaloridine results in increased expression of PTGR1 mRNA
CTD
PMID:18500788
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
decreases expression
ISO
Cephaloridine results in decreased expression of PTPN11 mRNA
CTD
PMID:18500788
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
PTPRB
protein tyrosine phosphatase receptor type B
decreases expression
ISO
Cephaloridine results in decreased expression of PTPRB mRNA
CTD
PMID:18500788
NCBI chr12:70,515,870...70,637,429
Ensembl chr12:70,515,870...70,637,440
G
PTPRN2
protein tyrosine phosphatase receptor type N2
increases expression
ISO
Cephaloridine results in increased expression of PTPRN2 mRNA
CTD
PMID:18500788
NCBI chr 7:157,539,056...158,587,823
Ensembl chr 7:157,539,056...158,587,823
G
PTRH1
peptidyl-tRNA hydrolase 1 homolog
increases expression
ISO
Cephaloridine results in increased expression of PTRH1 mRNA
CTD
PMID:18500788
NCBI chr 9:127,694,150...127,715,676
Ensembl chr 9:127,690,348...127,724,873
G
PVR
PVR cell adhesion molecule
increases expression
ISO
Cephaloridine results in increased expression of PVR mRNA
CTD
PMID:18500788
NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
G
RAB11FIP3
RAB11 family interacting protein 3
decreases expression
ISO
Cephaloridine results in decreased expression of RAB11FIP3 mRNA
CTD
PMID:18500788
NCBI chr16:425,649...523,011
Ensembl chr16:425,649...523,011
G
RAB31
RAB31, member RAS oncogene family
decreases expression
ISO
Cephaloridine results in decreased expression of RAB31 mRNA
CTD
PMID:18500788
NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551
G
RAD18
RAD18 E3 ubiquitin protein ligase
increases expression
ISO
Cephaloridine results in increased expression of RAD18 mRNA
CTD
PMID:18500788
NCBI chr 3:8,877,075...8,963,472
Ensembl chr 3:8,775,402...8,963,773
G
RB1
RB transcriptional corepressor 1
affects activity
ISO
Cephaloridine affects the activity of RB1 protein
CTD
PMID:18500788
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RBP2
retinol binding protein 2
increases expression
ISO
Cephaloridine results in increased expression of RBP2 mRNA
CTD
PMID:18500788
NCBI chr 3:139,452,884...139,476,516
Ensembl chr 3:139,452,884...139,480,747
G
RBSN
rabenosyn, RAB effector
decreases expression
ISO
Cephaloridine results in decreased expression of RBSN mRNA
CTD
PMID:18500788
NCBI chr 3:15,070,073...15,099,148
Ensembl chr 3:15,070,073...15,099,163
G
RDH16
retinol dehydrogenase 16
decreases expression
ISO
Cephaloridine results in decreased expression of RDH2 mRNA
CTD
PMID:18500788
NCBI chr12:56,951,431...56,957,608
Ensembl chr12:56,951,431...56,959,374
G
RECQL4
RecQ like helicase 4
increases expression
ISO
Cephaloridine results in increased expression of RECQL4 mRNA
CTD
PMID:18500788
NCBI chr 8:144,511,288...144,517,833
Ensembl chr 8:144,511,288...144,517,845
G
RELA
RELA proto-oncogene, NF-kB subunit
affects activity
ISO
Cephaloridine affects the activity of RELA protein
CTD
PMID:18500788
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RFC3
replication factor C subunit 3
increases expression
ISO
Cephaloridine results in increased expression of RFC3 mRNA
CTD
PMID:18500788
NCBI chr13:33,818,149...33,977,377
Ensembl chr13:33,818,069...33,966,558
G
RFC4
replication factor C subunit 4
increases expression
ISO
Cephaloridine results in increased expression of RFC4 mRNA
CTD
PMID:18500788
NCBI chr 3:186,789,900...186,806,482
Ensembl chr 3:186,789,880...186,807,058
G
RGN
regucalcin
decreases expression
ISO
Cephaloridine results in decreased expression of RGN mRNA
CTD
PMID:8584014 PMID:18500788
NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314
G
RGS11
regulator of G protein signaling 11
increases expression
ISO
Cephaloridine results in increased expression of RGS11 mRNA
CTD
PMID:18500788
NCBI chr16:268,307...275,944
Ensembl chr16:268,301...275,980
G
RHCG
Rh family C glycoprotein
increases expression
ISO
Cephaloridine results in increased expression of RHCG mRNA
CTD
PMID:18500788
NCBI chr15:89,471,407...89,496,583
Ensembl chr15:89,471,398...89,496,589
G
RHOBTB1
Rho related BTB domain containing 1
decreases expression
ISO
Cephaloridine results in decreased expression of RHOBTB1 mRNA
CTD
PMID:18500788
NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,440
G
RHPN2
rhophilin Rho GTPase binding protein 2
increases expression
ISO
Cephaloridine results in increased expression of RHPN2 mRNA
CTD
PMID:18500788
NCBI chr19:32,978,592...33,064,888
Ensembl chr19:32,978,592...33,064,888
G
RIDA
reactive intermediate imine deaminase A homolog
decreases expression
ISO
Cephaloridine results in decreased expression of RIDA mRNA
CTD
PMID:18500788
NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
G
RND1
Rho family GTPase 1
increases expression
ISO
Cephaloridine results in increased expression of RND1 mRNA
CTD
PMID:18500788
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
G
RNF227
ring finger protein 227
increases expression
ISO
Cephaloridine results in increased expression of RNF227 mRNA
CTD
PMID:18500788
NCBI chr17:7,913,324...7,916,318
Ensembl chr17:7,913,339...7,916,289
G
RPL23A
ribosomal protein L23a
increases expression
ISO
Cephaloridine results in increased expression of RPL23A mRNA
CTD
PMID:18500788
NCBI chr17:28,719,985...28,724,359
Ensembl chr17:28,719,985...28,724,359
G
RRM2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
Cephaloridine results in decreased expression of RRM2 mRNA
CTD
PMID:18500788
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
G
RUNX1T1
RUNX1 partner transcriptional co-repressor 1
decreases expression
ISO
Cephaloridine results in decreased expression of RUNX1T1 mRNA
CTD
PMID:18500788
NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,972...92,103,385
G
RXRG
retinoid X receptor gamma
increases expression
ISO
Cephaloridine results in increased expression of RXRG mRNA
CTD
PMID:18500788
NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355
G
SCGB3A1
secretoglobin family 3A member 1
increases expression
ISO
Cephaloridine results in increased expression of SCGB3A1 mRNA
CTD
PMID:18500788
NCBI chr 5:180,590,105...180,591,499
Ensembl chr 5:180,590,105...180,591,499
G
SCGB3A2
secretoglobin family 3A member 2
increases expression
ISO
Cephaloridine results in increased expression of SCGB3A2 mRNA
CTD
PMID:18500788
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SCT
secretin
increases expression
ISO
Cephaloridine results in increased expression of SCT mRNA
CTD
PMID:18500788
NCBI chr11:626,309...627,181
Ensembl chr11:626,309...627,181
G
SECTM1
secreted and transmembrane 1
increases expression
ISO
Cephaloridine results in increased expression of SECTM1A mRNA
CTD
PMID:18500788
NCBI chr17:82,321,024...82,333,959
Ensembl chr17:82,321,024...82,334,074
G
SELENOP
selenoprotein P
decreases expression
ISO
Cephaloridine results in decreased expression of SELENOP mRNA
CTD
PMID:18500788
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SEMA4C
semaphorin 4C
decreases expression
ISO
Cephaloridine results in decreased expression of SEMA4C mRNA
CTD
PMID:18500788
NCBI chr 2:96,859,718...96,870,830
Ensembl chr 2:96,859,718...96,870,757
G
SEPTIN10
septin 10
decreases expression
ISO
Cephaloridine results in decreased expression of SEPTIN10 mRNA
CTD
PMID:18500788
NCBI chr 2:109,542,799...109,613,966
Ensembl chr 2:109,542,799...109,614,143
G
SH2B2
SH2B adaptor protein 2
increases expression
ISO
Cephaloridine results in increased expression of SH2B2 mRNA
CTD
PMID:18500788
NCBI chr 7:102,285,141...102,321,711
Ensembl chr 7:102,285,091...102,321,711
G
SH3BP2
SH3 domain binding protein 2
increases expression
ISO
Cephaloridine results in increased expression of SH3BP2 mRNA
CTD
PMID:18500788
NCBI chr 4:2,793,085...2,841,096
Ensembl chr 4:2,793,071...2,841,098
G
SHROOM4
shroom family member 4
decreases expression
ISO
Cephaloridine results in decreased expression of SHROOM4 mRNA
CTD
PMID:18500788
NCBI chr X:50,575,534...50,814,194
Ensembl chr X:50,586,796...50,814,302
G
SKA1
spindle and kinetochore associated complex subunit 1
decreases expression
ISO
Cephaloridine results in decreased expression of SKA1 mRNA
CTD
PMID:18500788
NCBI chr18:50,375,046...50,394,168
Ensembl chr18:50,375,040...50,394,168
G
SLC15A3
solute carrier family 15 member 3
increases expression
ISO
Cephaloridine results in increased expression of SLC15A3 mRNA
CTD
PMID:18500788
NCBI chr11:60,937,084...60,952,176
Ensembl chr11:60,937,060...60,952,653
G
SLC16A12
solute carrier family 16 member 12
decreases expression
ISO
Cephaloridine results in decreased expression of SLC16A12 mRNA
CTD
PMID:18500788
NCBI chr10:89,430,299...89,556,704
Ensembl chr10:89,430,299...89,556,641
G
SLC16A14
solute carrier family 16 member 14
decreases expression
ISO
Cephaloridine results in decreased expression of SLC16A14 mRNA
CTD
PMID:18500788
NCBI chr 2:230,034,982...230,068,924
Ensembl chr 2:230,034,982...230,068,993
G
SLC1A5
solute carrier family 1 member 5
increases expression
ISO
Cephaloridine results in increased expression of SLC1A5 mRNA
CTD
PMID:18500788
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
G
SLC22A23
solute carrier family 22 member 23
decreases expression
ISO
Cephaloridine results in decreased expression of SLC22A23 mRNA
CTD
PMID:18500788
NCBI chr 6:3,268,973...3,457,050
Ensembl chr 6:3,268,962...3,457,050
G
SLC22A5
solute carrier family 22 member 5
decreases expression
ISO
Cephaloridine results in decreased expression of SLC22A5 mRNA
CTD
PMID:18500788
NCBI chr 5:132,369,710...132,395,612
Ensembl chr 5:132,369,710...132,395,613
G
SLC22A6
solute carrier family 22 member 6
increases import multiple interactions increases uptake
ISO EXP
SLC22A6 protein results in increased import of Cephaloridine Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Cephaloridine
CTD
PMID:10594788 PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of Cephaloridine Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC35D2
solute carrier family 35 member D2
increases expression
ISO
Cephaloridine results in increased expression of SLC35D2 mRNA
CTD
PMID:18500788
NCBI chr 9:96,313,444...96,383,711
Ensembl chr 9:96,313,444...96,383,711
G
SLC39A4
solute carrier family 39 member 4
increases expression
ISO
Cephaloridine results in increased expression of SLC39A4 mRNA
CTD
PMID:18500788
NCBI chr 8:144,412,414...144,416,844
Ensembl chr 8:144,409,742...144,416,844
G
SLC41A2
solute carrier family 41 member 2
increases expression
ISO
Cephaloridine results in increased expression of SLC41A2 mRNA
CTD
PMID:18500788
NCBI chr12:104,801,801...104,958,746
Ensembl chr12:104,801,801...104,958,744
G
SLC46A3
solute carrier family 46 member 3
increases expression
ISO
Cephaloridine results in increased expression of SLC46A3 mRNA
CTD
PMID:18500788
NCBI chr13:28,700,080...28,718,970
Ensembl chr13:28,700,064...28,718,970
G
SLC4A4
solute carrier family 4 member 4
decreases expression
ISO
Cephaloridine results in decreased expression of SLC4A4 mRNA
CTD
PMID:18500788
NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087
G
SLC5A3
solute carrier family 5 member 3
increases expression
ISO
Cephaloridine results in increased expression of SLC5A3 mRNA
CTD
PMID:18500788
NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260
G
SLC7A10
solute carrier family 7 member 10
increases expression
ISO
Cephaloridine results in increased expression of SLC7A10 mRNA
CTD
PMID:18500788
NCBI chr19:33,208,664...33,225,850
Ensembl chr19:33,208,664...33,225,850
G
SLC7A5
solute carrier family 7 member 5
increases expression
ISO
Cephaloridine results in increased expression of SLC7A5 mRNA
CTD
PMID:18500788
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SLC7A7
solute carrier family 7 member 7
decreases expression
ISO
Cephaloridine results in decreased expression of SLC7A7 mRNA
CTD
PMID:18500788
NCBI chr14:22,773,222...22,819,791
Ensembl chr14:22,773,222...22,829,820
G
SLC8A1
solute carrier family 8 member A1
decreases expression
ISO
Cephaloridine results in decreased expression of SLC8A1 mRNA
CTD
PMID:18500788
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
G
SLPI
secretory leukocyte peptidase inhibitor
increases expression
ISO
Cephaloridine results in increased expression of SLPI mRNA
CTD
PMID:18500788
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SMYD1
SET and MYND domain containing 1
increases expression
ISO
Cephaloridine results in increased expression of SMYD1 mRNA
CTD
PMID:18500788
NCBI chr 2:88,067,825...88,113,384
Ensembl chr 2:88,067,825...88,113,384
G
SNAPC2
small nuclear RNA activating complex polypeptide 2
increases expression
ISO
Cephaloridine results in increased expression of SNAPC2 mRNA
CTD
PMID:18500788
NCBI chr19:7,920,338...7,923,250
Ensembl chr19:7,920,338...7,923,250
G
SOCS3
suppressor of cytokine signaling 3
decreases expression
ISO
Cephaloridine results in decreased expression of SOCS3 mRNA
CTD
PMID:18500788
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
G
SPHK1
sphingosine kinase 1
increases expression
ISO
Cephaloridine results in increased expression of SPHK1 mRNA
CTD
PMID:18500788
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
G
SPINK1
serine peptidase inhibitor Kazal type 1
decreases expression
ISO
Cephaloridine results in decreased expression of SPINK1 mRNA
CTD
PMID:18500788
NCBI chr 5:147,824,582...147,839,196
Ensembl chr 5:147,824,572...147,831,671
G
SRPRA
SRP receptor subunit alpha
decreases expression
ISO
Cephaloridine results in decreased expression of SRPRA mRNA
CTD
PMID:18500788
NCBI chr11:126,235,930...126,268,895
Ensembl chr11:126,262,938...126,269,144
G
STAT3
signal transducer and activator of transcription 3
increases expression
ISO
Cephaloridine results in increased expression of STAT3 mRNA
CTD
PMID:18500788
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STK35
serine/threonine kinase 35
increases expression
ISO
Cephaloridine results in increased expression of STK35 mRNA
CTD
PMID:18500788
NCBI chr20:2,101,827...2,148,555
Ensembl chr20:2,101,827...2,177,038
G
STRA6
signaling receptor and transporter of retinol STRA6
decreases expression
ISO
Cephaloridine results in decreased expression of STRA6 mRNA
CTD
PMID:18500788
NCBI chr15:74,179,466...74,212,259
Ensembl chr15:74,179,466...74,212,267
G
SULT1C2
sulfotransferase family 1C member 2
decreases expression
ISO
Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA
CTD
PMID:18500788
NCBI chr 2:108,288,895...108,309,915
Ensembl chr 2:108,288,639...108,309,915
G
SULT4A1
sulfotransferase family 4A member 1
increases expression
ISO
Cephaloridine results in increased expression of SULT4A1 mRNA
CTD
PMID:18500788
NCBI chr22:43,824,509...43,862,513
Ensembl chr22:43,824,509...43,862,513
G
SURF6
surfeit 6
decreases expression
ISO
Cephaloridine results in decreased expression of SURF6 mRNA
CTD
PMID:18500788
NCBI chr 9:133,328,776...133,336,188
Ensembl chr 9:133,328,776...133,336,188
G
SUSD2
sushi domain containing 2
decreases expression
ISO
Cephaloridine results in decreased expression of SUSD2 mRNA
CTD
PMID:18500788
NCBI chr22:24,181,487...24,189,106
Ensembl chr22:24,181,487...24,189,106
G
SYNE1
spectrin repeat containing nuclear envelope protein 1
decreases expression
ISO
Cephaloridine results in decreased expression of SYNE1 mRNA
CTD
PMID:18500788
NCBI chr 6:152,121,687...152,637,362
Ensembl chr 6:152,121,687...152,637,801
G
SYNE2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
Cephaloridine results in decreased expression of SYNE2 mRNA
CTD
PMID:18500788
NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
G
SYTL5
synaptotagmin like 5
increases expression
ISO
Cephaloridine results in increased expression of SYTL5 mRNA
CTD
PMID:18500788
NCBI chr X:37,888,915...38,128,820
Ensembl chr X:38,006,553...38,128,819
G
TAC3
tachykinin precursor 3
increases expression
ISO
Cephaloridine results in increased expression of TAC2 mRNA
CTD
PMID:18500788
NCBI chr12:57,010,000...57,016,529
Ensembl chr12:57,010,000...57,028,883
G
TBX3
T-box transcription factor 3
decreases expression
ISO
Cephaloridine results in decreased expression of TBX3 mRNA
CTD
PMID:18500788
NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175
G
TCF12
transcription factor 12
decreases expression
ISO
Cephaloridine results in decreased expression of TCF12 mRNA
CTD
PMID:18500788
NCBI chr15:56,918,090...57,291,310
Ensembl chr15:56,918,623...57,299,281
G
TCF19
transcription factor 19
increases expression
ISO
Cephaloridine results in increased expression of TCF19 mRNA
CTD
PMID:18500788
NCBI chr 6:31,158,589...31,164,215
Ensembl chr 6:31,158,331...31,167,159
G
TFRC
transferrin receptor
increases expression
ISO
Cephaloridine results in increased expression of TFRC mRNA
CTD
PMID:18500788
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
G
TICRR
TOPBP1 interacting checkpoint and replication regulator
increases expression
ISO
Cephaloridine results in increased expression of TICRR mRNA
CTD
PMID:18500788
NCBI chr15:89,575,469...89,628,023
Ensembl chr15:89,575,469...89,631,056
G
TIMELESS
timeless circadian regulator
increases expression
ISO
Cephaloridine results in increased expression of TIMELESS mRNA
CTD
PMID:18500788
NCBI chr12:56,416,363...56,449,426
Ensembl chr12:56,416,363...56,449,426
G
TIMP1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
Cephaloridine results in increased expression of TIMP1 mRNA
CTD
PMID:18500788
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TLR2
toll like receptor 2
increases expression
ISO
Cephaloridine results in increased expression of TLR2 mRNA
CTD
PMID:18500788
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TMEM163
transmembrane protein 163
increases expression
ISO
Cephaloridine results in increased expression of TMEM163 mRNA
CTD
PMID:18500788
NCBI chr 2:134,455,759...134,719,000
Ensembl chr 2:134,455,759...134,719,000
G
TMEM252
transmembrane protein 252
decreases expression
ISO
Cephaloridine results in decreased expression of TMEM252 mRNA
CTD
PMID:18500788
NCBI chr 9:68,536,580...68,540,883
Ensembl chr 9:68,536,580...68,540,883
G
TMEM270
transmembrane protein 270
increases expression
ISO
Cephaloridine results in increased expression of TMEM270 mRNA
CTD
PMID:18500788
NCBI chr 7:73,860,848...73,865,890
Ensembl chr 7:73,861,159...73,865,890
G
TMEM63C
transmembrane protein 63C
increases expression
ISO
Cephaloridine results in increased expression of TMEM63C mRNA
CTD
PMID:18500788
NCBI chr14:77,181,798...77,259,495
Ensembl chr14:77,116,568...77,259,495
G
TMEM86A
transmembrane protein 86A
decreases expression
ISO
Cephaloridine results in decreased expression of TMEM86A mRNA
CTD
PMID:18500788
NCBI chr11:18,698,779...18,704,785
Ensembl chr11:18,693,122...18,704,785
G
TNFRSF12A
TNF receptor superfamily member 12A
increases expression
ISO
Cephaloridine results in increased expression of TNFRSF12A mRNA
CTD
PMID:18500788
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF1A
TNF receptor superfamily member 1A
increases expression
ISO
Cephaloridine results in increased expression of TNFRSF1A mRNA
CTD
PMID:18500788
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNS1
tensin 1
decreases expression
ISO
Cephaloridine results in decreased expression of TNS1 mRNA
CTD
PMID:18500788
NCBI chr 2:217,799,791...218,033,982
Ensembl chr 2:217,799,588...218,033,982
G
TNS4
tensin 4
increases expression
ISO
Cephaloridine results in increased expression of TNS4 mRNA
CTD
PMID:18500788
NCBI chr17:40,475,834...40,501,623
Ensembl chr17:40,475,828...40,501,623
G
TONSL
tonsoku like, DNA repair protein
increases expression
ISO
Cephaloridine results in increased expression of TONSL mRNA
CTD
PMID:18500788
NCBI chr 8:144,428,775...144,444,440
Ensembl chr 8:144,428,775...144,444,440
G
TOP2A
DNA topoisomerase II alpha
decreases expression
ISO
Cephaloridine results in decreased expression of TOP2A mRNA
CTD
PMID:18500788
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TPH1
tryptophan hydroxylase 1
increases expression
ISO
Cephaloridine results in increased expression of TPH1 mRNA
CTD
PMID:18500788
NCBI chr11:18,017,555...18,046,269
Ensembl chr11:18,017,555...18,046,269
G
TRIB3
tribbles pseudokinase 3
increases expression
ISO
Cephaloridine results in increased expression of TRIB3 mRNA
CTD
PMID:18500788
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIL
TLR4 interactor with leucine rich repeats
decreases expression
ISO
Cephaloridine results in decreased expression of TRIL mRNA
CTD
PMID:18500788
NCBI chr 7:28,953,358...28,958,330
Ensembl chr 7:28,953,358...28,958,330
G
TRPC6
transient receptor potential cation channel subfamily C member 6
increases expression
ISO
Cephaloridine results in increased expression of TRPC6 mRNA
CTD
PMID:18500788
NCBI chr11:101,451,564...101,584,007
Ensembl chr11:101,451,564...101,872,562
G
TTC39A
tetratricopeptide repeat domain 39A
increases expression
ISO
Cephaloridine results in increased expression of TTC39A mRNA
CTD
PMID:18500788
NCBI chr 1:51,287,258...51,345,116
Ensembl chr 1:51,287,258...51,345,116
G
TTK
TTK protein kinase
decreases expression
ISO
Cephaloridine results in decreased expression of TTK mRNA
CTD
PMID:18500788
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
G
TTLL2
tubulin tyrosine ligase like 2
increases expression
ISO
Cephaloridine results in increased expression of TTLL2 mRNA
CTD
PMID:18500788
NCBI chr 6:167,325,086...167,342,688
Ensembl chr 6:167,325,071...167,359,503
G
TUBB3
tubulin beta 3 class III
increases expression
ISO
Cephaloridine results in increased expression of TUBB3 mRNA
CTD
PMID:18500788
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
G
TUBB6
tubulin beta 6 class V
increases expression
ISO
Cephaloridine results in increased expression of TUBB6 mRNA
CTD
PMID:18500788
NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320
G
TYMS
thymidylate synthetase
increases expression
ISO
Cephaloridine results in increased expression of TYMS mRNA
CTD
PMID:18500788
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
G
UBD
ubiquitin D
increases expression
ISO
Cephaloridine results in increased expression of UBD mRNA
CTD
PMID:18500788
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
UBE2C
ubiquitin conjugating enzyme E2 C
decreases expression
ISO
Cephaloridine results in decreased expression of UBE2C mRNA
CTD
PMID:18500788
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UBE2L6
ubiquitin conjugating enzyme E2 L6
increases expression
ISO
Cephaloridine results in increased expression of UBE2L6 mRNA
CTD
PMID:18500788
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
G
UBL7
ubiquitin like 7
increases expression
ISO
Cephaloridine results in increased expression of UBL7 mRNA
CTD
PMID:18500788
NCBI chr15:74,445,977...74,461,188
Ensembl chr15:74,445,977...74,461,182
G
UCHL1
ubiquitin C-terminal hydrolase L1
increases expression
ISO
Cephaloridine results in increased expression of UCHL1 mRNA
CTD
PMID:18500788
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
G
UGT1A3
UDP glucuronosyltransferase family 1 member A3
increases expression
ISO
Cephaloridine results in increased expression of UGT1A2 mRNA
CTD
PMID:18500788
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
Cephaloridine results in increased expression of UGT1A6 mRNA
CTD
PMID:18500788
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
UGT2B7
UDP glucuronosyltransferase family 2 member B7
increases expression
ISO
Cephaloridine results in increased expression of UGT2B7 mRNA
CTD
PMID:18500788
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
G
UHMK1
U2AF homology motif kinase 1
increases expression
ISO
Cephaloridine results in increased expression of UHMK1 mRNA
CTD
PMID:18500788
NCBI chr 1:162,497,174...162,529,631
Ensembl chr 1:162,497,251...162,529,631
G
UPP1
uridine phosphorylase 1
increases expression
ISO
Cephaloridine results in increased expression of UPP1 mRNA
CTD
PMID:18500788
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
G
USP24
ubiquitin specific peptidase 24
decreases expression
ISO
Cephaloridine results in decreased expression of USP24 mRNA
CTD
PMID:18500788
NCBI chr 1:55,066,359...55,215,364
Ensembl chr 1:55,066,359...55,215,378
G
VCAM1
vascular cell adhesion molecule 1
increases expression
ISO
Cephaloridine results in increased expression of VCAM1 mRNA
CTD
PMID:18500788
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VPREB3
V-set pre-B cell surrogate light chain 3
increases expression
ISO
Cephaloridine results in increased expression of VPREB3 mRNA
CTD
PMID:18500788
NCBI chr22:23,752,743...23,754,425
Ensembl chr22:23,752,743...23,754,425
G
WDHD1
WD repeat and HMG-box DNA binding protein 1
increases expression
ISO
Cephaloridine results in increased expression of WDHD1 mRNA
CTD
PMID:18500788
NCBI chr14:54,938,949...55,027,099
Ensembl chr14:54,938,949...55,027,105
G
ZC3H13
zinc finger CCCH-type containing 13
decreases expression
ISO
Cephaloridine results in decreased expression of ZC3H13 mRNA
CTD
PMID:18500788
NCBI chr13:45,954,465...46,052,746
Ensembl chr13:45,954,465...46,052,759
G
ZDHHC18
zinc finger DHHC-type palmitoyltransferase 18
decreases expression
ISO
Cephaloridine results in decreased expression of ZDHHC18 mRNA
CTD
PMID:18500788
NCBI chr 1:26,826,688...26,857,604
Ensembl chr 1:26,826,688...26,857,604
G
ZFAND2A
zinc finger AN1-type containing 2A
decreases expression
ISO
Cephaloridine results in decreased expression of ZFAND2A mRNA
CTD
PMID:18500788
NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
G
ZNF367
zinc finger protein 367
increases expression
ISO
Cephaloridine results in increased expression of ZFP367 mRNA
CTD
PMID:18500788
NCBI chr 9:96,385,941...96,418,370
Ensembl chr 9:96,385,941...96,418,370
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Cephalothin results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
CASP3
caspase 3
multiple interactions
EXP
Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:15012731
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
FGF19
fibroblast growth factor 19
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
CTD
PMID:24657338
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr 7:44,512,535...44,541,330
Ensembl chr 7:44,512,535...44,541,330
G
NR5A2
nuclear receptor subfamily 5 group A member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
SLC10A1
solute carrier family 10 member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC25A20
solute carrier family 25 member 20
multiple interactions
ISO
Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
G
SLC51B
SLC51 subunit beta
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
G
TP53
tumor protein p53
increases expression
EXP
Cephalothin results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
VDR
vitamin D receptor
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
CTD
PMID:24657338
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
DHFR
dihydrofolate reductase
decreases activity
EXP
Cefazolin results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
GSR
glutathione-disulfide reductase
multiple interactions increases expression
ISO
Cefazolin results in increased expression of and results in decreased activity of GSR protein Cefazolin results in increased expression of GSR mRNA
CTD
PMID:32196862
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HLA-DOA
major histocompatibility complex, class II, DO alpha
affects expression
EXP
Cefazolin affects the expression of HLA-DOA mRNA
CTD
PMID:25811541
NCBI chr 6:33,004,182...33,009,591
Ensembl chr 6:33,004,182...33,009,591
G
HLA-G
major histocompatibility complex, class I, G
affects expression
EXP
Cefazolin affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
SLC22A8
solute carrier family 22 member 8
increases uptake
EXP
SLC22A8 protein results in increased uptake of Cefazolin
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC25A20
solute carrier family 25 member 20
multiple interactions
ISO
Cefazolin binds to and results in decreased activity of SLC25A20 protein; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
G
SLC22A6
solute carrier family 22 member 6
multiple interactions increases uptake
EXP
cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
multiple interactions increases uptake
EXP
cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
ARHGAP45
Rho GTPase activating protein 45
affects expression
EXP
cefepime affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr19:1,065,959...1,086,628
Ensembl chr19:1,065,923...1,086,628
G
CAT
catalase
multiple interactions
ISO
cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein]
CTD
PMID:18781908
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
DHFR
dihydrofolate reductase
decreases activity
EXP
cefepime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
affects expression
EXP
cefepime affects the expression of HLA-DRB1 mRNA
CTD
PMID:25811541
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
PGD
phosphogluconate dehydrogenase
decreases activity
ISO
cefepime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
RAB8A
RAB8A, member RAS oncogene family
increases uptake multiple interactions
ISO
RAB8A protein results in increased uptake of Cefixime [RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234
G
SLC15A1
solute carrier family 15 member 1
multiple interactions increases uptake
ISO
[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime SLC15A1 protein results in increased uptake of Cefixime
CTD
PMID:19074526
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Cefmetazole
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
SLC25A20
solute carrier family 25 member 20
multiple interactions
ISO
Cefonicid binds to and results in decreased activity of SLC25A20 protein; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
G
SLC22A7
solute carrier family 22 member 7
multiple interactions
ISO
Cefoperazone inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]
CTD
PMID:12065749
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SLC22A6
solute carrier family 22 member 6
multiple interactions
EXP
cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of cefoselis cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Cefotaxime results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
HLA-F
major histocompatibility complex, class I, F
affects expression
EXP
Cefotaxime affects the expression of HLA-F mRNA
CTD
PMID:25811541
NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528
G
IL10
interleukin 10
multiple interactions
EXP
Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
PGD
phosphogluconate dehydrogenase
decreases activity
ISO
Cefotaxime results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
TP53
tumor protein p53
increases expression
EXP
Cefotaxime results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
KCNH2
potassium voltage-gated channel subfamily H member 2
decreases activity
EXP
Cefotetan results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
SLC22A6
solute carrier family 22 member 6
multiple interactions
EXP
Cefotiam inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of Cefotiam Cefotiam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
HLA-A
major histocompatibility complex, class I, A
affects expression
EXP
Cefoxitin affects the expression of HLA-A mRNA
CTD
PMID:25811541
NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
affects expression
EXP
Cefoxitin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
IFNG
interferon gamma
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]
CTD
PMID:37269894
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]
CTD
PMID:37269894
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IL10
interleukin 10
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL10 mRNA]
CTD
PMID:37269894
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1B
interleukin 1 beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL1B mRNA]
CTD
PMID:37269894
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]
CTD
PMID:37269894
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MYD88
MYD88 innate immune signal transduction adaptor
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]
CTD
PMID:37269894
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]
CTD
PMID:37269894
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
TGFB1
transforming growth factor beta 1
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]
CTD
PMID:37269894
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TLR2
toll like receptor 2
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]
CTD
PMID:37269894
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TNF
tumor necrosis factor
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]
CTD
PMID:37269894
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TRAF6
TNF receptor associated factor 6
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TRAF6 mRNA]
CTD
PMID:37269894
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
G
PRL
prolactin
increases expression
EXP
Cefpodoxime results in increased expression of PRL protein
CTD
PMID:20083845
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
DEFB4A
defensin beta 4A
multiple interactions
EXP
Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of and results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased secretion of DEFB4A protein]
CTD
PMID:27397760 PMID:28720485
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
G
IL1B
interleukin 1 beta
multiple interactions
EXP
Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]
CTD
PMID:27397760
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
TLR2
toll like receptor 2
multiple interactions
EXP
Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR2 protein]
CTD
PMID:27397760
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
multiple interactions
EXP
Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR4 protein]
CTD
PMID:28720485
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions
EXP
Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in increased secretion of TNF protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of TNF protein]
CTD
PMID:28720485
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Ceftazidime
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
DHFR
dihydrofolate reductase
decreases activity
EXP
Ceftazidime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
HSF1
heat shock transcription factor 1
decreases activity
EXP
Ceftazidime results in decreased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
G
IL10
interleukin 10
multiple interactions
EXP
Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
SLC15A1
solute carrier family 15 member 1
multiple interactions
EXP
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of ceftibuten
CTD
PMID:14567632
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
SLC22A6
solute carrier family 22 member 6
increases uptake multiple interactions
EXP
SLC22A6 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of ceftibuten ceftibuten inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
DHFR
dihydrofolate reductase
decreases activity
EXP
Ceftizoxime results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
SLC22A6
solute carrier family 22 member 6
multiple interactions increases uptake
EXP
Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of Ceftizoxime
CTD
PMID:16098483
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases uptake multiple interactions
EXP
SLC22A8 protein results in increased uptake of Ceftizoxime Ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
ACE2
angiotensin converting enzyme 2
decreases expression
ISO
Ceftriaxone results in decreased expression of ACE2 mRNA
CTD
PMID:29745864
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACTB
actin beta
increases expression
ISO
Ceftriaxone results in increased expression of ACTB mRNA
CTD
PMID:29745864
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
G
BACE1
beta-secretase 1
decreases expression
ISO
Ceftriaxone results in decreased expression of BACE1 mRNA
CTD
PMID:29745864
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
G
CAT
catalase
decreases expression multiple interactions
ISO
Ceftriaxone results in decreased expression of CAT protein Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD
PMID:19442074 PMID:25053526
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
DHFR
dihydrofolate reductase
decreases activity
EXP
Ceftriaxone results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
ECE1
endothelin converting enzyme 1
increases expression
ISO
Ceftriaxone results in increased expression of ECE1 mRNA
CTD
PMID:29745864
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
G
EPO
erythropoietin
increases expression
ISO
Ceftriaxone results in increased expression of EPO mRNA
CTD
PMID:29745864
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
IDE
insulin degrading enzyme
increases expression
ISO
Ceftriaxone results in increased expression of IDE mRNA
CTD
PMID:29745864
NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
G
IL1B
interleukin 1 beta
multiple interactions
ISO
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]]
CTD
PMID:25053526
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
MME
membrane metalloendopeptidase
increases expression
ISO
Ceftriaxone results in increased expression of MME mRNA
CTD
PMID:29745864
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
SLC1A2
solute carrier family 1 member 2
multiple interactions increases expression
ISO
Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein] Ceftriaxone results in increased expression of SLC1A2 protein
CTD
PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
G
SLC7A11
solute carrier family 7 member 11
multiple interactions
ISO
Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
CTD
PMID:19717140
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
TNF
tumor necrosis factor
multiple interactions
ISO
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]]
CTD
PMID:25053526
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CAT
catalase
decreases activity
ISO
Cefuroxime results in decreased activity of CAT protein
CTD
PMID:30797828
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
affects expression
EXP
Cefuroxime affects the expression of HLA-DQB1 mRNA
CTD
PMID:25811541
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-E
major histocompatibility complex, class I, E
affects expression
EXP
Cefuroxime affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
G
IL10
interleukin 10
multiple interactions
EXP
Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
CTD
PMID:16939481
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
NFE2L2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Cefuroxime results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NR1I3
nuclear receptor subfamily 1 group I member 3
decreases activity
ISO
Cefuroxime results in decreased activity of NR1I3 protein
CTD
PMID:30203046
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
PPARA
peroxisome proliferator activated receptor alpha
decreases activity
ISO
Cefuroxime results in decreased activity of PPARA protein
CTD
PMID:30203046
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
affects expression
EXP
Cephalexin affects the expression of HLA-DPA1 mRNA
CTD
PMID:25811541
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
SLC15A1
solute carrier family 15 member 1
increases transport
ISO
SLC15A1 protein results in increased transport of Cephalexin
CTD
PMID:19881305
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of cephalosporin C
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
SLC15A1
solute carrier family 15 member 1
multiple interactions
EXP
[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of Cephradine
CTD
PMID:14567632
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
G
ABCB11
ATP binding cassette subfamily B member 11
decreases expression multiple interactions
EXP
Clavulanic Acid results in decreased expression of ABCB11 mRNA Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCB11 mRNA]
CTD
PMID:34767876
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCB4
ATP binding cassette subfamily B member 4
decreases expression
EXP
Clavulanic Acid results in decreased expression of ABCB4 mRNA
CTD
PMID:34767876
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
G
ABCC2
ATP binding cassette subfamily C member 2
increases expression
EXP
Clavulanic Acid results in increased expression of ABCC2 mRNA
CTD
PMID:34767876
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCG5
ATP binding cassette subfamily G member 5
multiple interactions decreases expression
EXP
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ABCG5 mRNA]
CTD
PMID:34767876
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ADH1A
alcohol dehydrogenase 1A (class I), alpha polypeptide
multiple interactions decreases expression
EXP
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ADH1A mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ADH1A mRNA]
CTD
PMID:34767876
NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
Clavulanic Acid results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
CXCL8
C-X-C motif chemokine ligand 8
decreases expression increases expression
EXP
Clavulanic Acid results in decreased expression of CXCL8 mRNA Clavulanic Acid results in increased expression of CXCL8 mRNA
CTD
PMID:32816093
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
decreases expression
EXP
Clavulanic Acid results in decreased expression of CYP27A1 mRNA
CTD
PMID:34767876
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
Clavulanic Acid results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
Clavulanic Acid results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
EREG
epiregulin
decreases expression increases expression
EXP
Clavulanic Acid results in decreased expression of EREG mRNA Clavulanic Acid results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
G
FGF19
fibroblast growth factor 19
increases expression
EXP
Clavulanic Acid results in increased expression of FGF19 mRNA
CTD
PMID:34767876
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
EXP
Clavulanic Acid results in increased expression of G6PD mRNA
CTD
PMID:34767876
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GCLC
glutamate-cysteine ligase catalytic subunit
increases expression
EXP
Clavulanic Acid results in increased expression of GCLC mRNA
CTD
PMID:34767876
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Clavulanic Acid results in increased expression of GCLM mRNA
CTD
PMID:34767876
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GPX2
glutathione peroxidase 2
increases expression
EXP
Clavulanic Acid results in increased expression of GPX2 mRNA
CTD
PMID:34767876
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GSR
glutathione-disulfide reductase
increases expression
EXP
Clavulanic Acid results in increased expression of GSR mRNA
CTD
PMID:34767876
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
IL1A
interleukin 1 alpha
increases expression
EXP
Clavulanic Acid results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases expression
EXP
Clavulanic Acid results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL24
interleukin 24
increases expression decreases expression
EXP
Clavulanic Acid results in increased expression of IL24 mRNA Clavulanic Acid results in decreased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
G
LSS
lanosterol synthase
decreases expression
EXP
Clavulanic Acid results in decreased expression of LSS mRNA
CTD
PMID:34767876
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
ME1
malic enzyme 1
increases expression
EXP
Clavulanic Acid results in increased expression of ME1 mRNA
CTD
PMID:34767876
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MET
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Clavulanic Acid results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MVK
mevalonate kinase
decreases expression
EXP
Clavulanic Acid results in decreased expression of MVK mRNA
CTD
PMID:34767876
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
NR0B2
nuclear receptor subfamily 0 group B member 2
increases expression
EXP
Clavulanic Acid results in increased expression of NR0B2 mRNA
CTD
PMID:34767876
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
Clavulanic Acid results in decreased expression of SCD mRNA
CTD
PMID:34767876
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SLC10A1
solute carrier family 10 member 1
decreases expression
EXP
Clavulanic Acid results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC51A
solute carrier family 51 member A
decreases expression multiple interactions
EXP
Clavulanic Acid results in decreased expression of SLC51A mRNA Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA]
CTD
PMID:34767876
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC7A11
solute carrier family 7 member 11
increases expression decreases expression
EXP
Clavulanic Acid results in increased expression of SLC7A11 mRNA Clavulanic Acid results in decreased expression of SLC7A11 mRNA
CTD
PMID:32816093 PMID:34767876
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLPI
secretory leukocyte peptidase inhibitor
increases expression
EXP
Clavulanic Acid results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SREBF1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
Clavulanic Acid results in decreased expression of SREBF1 mRNA
CTD
PMID:34767876
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
TKT
transketolase
increases expression
EXP
Clavulanic Acid results in increased expression of TKT mRNA
CTD
PMID:34767876
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TNFAIP6
TNF alpha induced protein 6
increases expression
EXP
Clavulanic Acid results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
Clavulanic Acid results in increased expression of TXNRD1 mRNA
CTD
PMID:34767876
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
ABCB11
ATP binding cassette subfamily B member 11
decreases activity
EXP ISO
Cloxacillin results in decreased activity of ABCB11 protein
CTD
PMID:15618715
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
CASP3
caspase 3
increases activity multiple interactions
EXP
Cloxacillin results in increased activity of CASP3 protein [Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Cloxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
IL1B
interleukin 1 beta
multiple interactions
EXP
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
EXP
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
TNF
tumor necrosis factor
multiple interactions
EXP
[Cloxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Cloxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Cloxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ABCB11
ATP binding cassette subfamily B member 11
decreases activity
EXP
Dicloxacillin results in decreased activity of ABCB11 protein
CTD
PMID:20829430
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
AGER
advanced glycosylation end-product specific receptor
multiple interactions increases expression
ISO
AGER protein affects the reaction [Dicloxacillin results in increased expression of GPT protein] Dicloxacillin results in increased expression of AGER mRNA
CTD
PMID:24747151
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression multiple interactions
ISO
Dicloxacillin results in increased expression of CXCL1 mRNA Progesterone promotes the reaction [Dicloxacillin results in increased expression of CXCL1 mRNA]
CTD
PMID:22157104
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[Progesterone co-treated with Dicloxacillin] results in increased expression of CXCL2 mRNA Dicloxacillin results in increased expression of CXCL2 mRNA
CTD
PMID:22157104 PMID:24747151
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions increases expression
EXP
Dicloxacillin results in increased expression of and results in increased activity of CYP3A4 protein Dicloxacillin results in increased expression of CYP3A4 mRNA
CTD
PMID:18505790
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
GPT
glutamic--pyruvic transaminase
multiple interactions increases expression
ISO
AGER protein affects the reaction [Dicloxacillin results in increased expression of GPT protein]; eritoran inhibits the reaction [Dicloxacillin results in increased expression of GPT protein]
CTD
PMID:24747151
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
HMGB1
high mobility group box 1
increases expression
ISO
Dicloxacillin results in increased expression of HMGB1 protein
CTD
PMID:24747151
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
ICAM1
intercellular adhesion molecule 1
increases expression
EXP
Dicloxacillin results in increased expression of ICAM1 protein
CTD
PMID:14729754
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IL1B
interleukin 1 beta
increases expression
ISO
Dicloxacillin results in increased expression of IL1B mRNA
CTD
PMID:24747151
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL4
interleukin 4
increases response to substance increases expression
ISO
IL4 results in increased susceptibility to Dicloxacillin Dicloxacillin results in increased expression of IL4 protein
CTD
PMID:21094227
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
NLRP3
NLR family pyrin domain containing 3
increases expression
ISO
Dicloxacillin results in increased expression of NLRP3 mRNA
CTD
PMID:24747151
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Dicloxacillin results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
S100A8
S100 calcium binding protein A8
increases expression
ISO EXP
Dicloxacillin results in increased expression of S100A8 mRNA
CTD
PMID:24747151 PMID:28138970
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
increases expression
ISO
Dicloxacillin results in increased expression of S100A9 mRNA
CTD
PMID:24747151
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
EXP
Ezetimibe results in decreased expression of ABCA1 mRNA
CTD
PMID:16177187
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
EXP
Ezetimibe results in decreased activity of ABCB11 protein Ezetimibe inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
APOA1
apolipoprotein A1
multiple interactions
EXP
[Niacin co-treated with Ezetimibe co-treated with Simvastatin] results in increased expression of APOA1 protein; [Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein; Niacin promotes the reaction [[Simvastatin co-treated with Ezetimibe] results in increased expression of APOA1 protein]
CTD
PMID:18420099 PMID:20152243
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
CRP
C-reactive protein
multiple interactions
EXP
[Ezetimibe co-treated with Simvastatin] results in decreased expression of CRP protein; [Simvastatin co-treated with Ezetimibe] promotes the reaction [Niacin results in decreased expression of CRP protein]
CTD
PMID:18420099 PMID:20152243
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions increases activity
EXP
[Simvastatin co-treated with Ezetimibe] results in increased expression of HMGCR mRNA Ezetimibe results in increased activity of HMGCR protein
CTD
PMID:17980884
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
LDLR
low density lipoprotein receptor
multiple interactions
EXP
[Simvastatin co-treated with Ezetimibe] results in increased expression of LDLR mRNA
CTD
PMID:17980884
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
MIR221
microRNA 221
decreases expression
EXP
Ezetimibe results in decreased expression of MIR221
CTD
PMID:25517390
NCBI chr X:45,746,157...45,746,266
Ensembl chr X:45,746,157...45,746,266
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
decreases expression decreases activity decreases response to substance
EXP
Ezetimibe results in decreased expression of NPC1L1 mRNA Ezetimibe results in decreased activity of NPC1L1 protein NPC1L1 exon SNP results in decreased susceptibility to Ezetimibe
CTD
PMID:15679830 PMID:16177187 PMID:28057006
NCBI chr 7:44,512,535...44,541,330
Ensembl chr 7:44,512,535...44,541,330
G
NR1H2
nuclear receptor subfamily 1 group H member 2
decreases expression
EXP
Ezetimibe results in decreased expression of NR1H2 mRNA
CTD
PMID:16177187
NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
G
PCSK9
proprotein convertase subtilisin/kexin type 9
multiple interactions
EXP
[Simvastatin co-treated with Ezetimibe] results in increased expression of PCSK9 mRNA
CTD
PMID:17980884
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,447...55,064,852
G
PGR
progesterone receptor
multiple interactions
EXP
Ezetimibe binds to and results in decreased activity of PGR protein
CTD
PMID:25752796
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PLA2G7
phospholipase A2 group VII
multiple interactions
EXP
[orlistat co-treated with Ezetimibe] results in decreased activity of PLA2G7 protein
CTD
PMID:18513463
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
RARG
retinoic acid receptor gamma
decreases expression
EXP
Ezetimibe results in decreased expression of RARG mRNA
CTD
PMID:16177187
NCBI chr12:53,210,569...53,232,209
Ensembl chr12:53,210,567...53,232,980
G
SCARB1
scavenger receptor class B member 1
decreases expression
EXP
Ezetimibe results in decreased expression of SCARB1 mRNA
CTD
PMID:16177187
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SREBF1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
Ezetimibe results in decreased expression of SREBF1 mRNA
CTD
PMID:16177187
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
decreases expression
EXP
Ezetimibe results in decreased expression of SREBF2 mRNA
CTD
PMID:16177187
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
TNF
tumor necrosis factor
multiple interactions
ISO
[Metformin co-treated with rosiglitazone co-treated with Valsartan co-treated with Ezetimibe] inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]; Ezetimibe inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]
CTD
PMID:16865780
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
EXP
UGT1A1 protein results in increased glucuronidation of Ezetimibe
CTD
PMID:14977865
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A3
UDP glucuronosyltransferase family 1 member A3
increases glucuronidation
EXP
UGT1A3 protein results in increased glucuronidation of Ezetimibe
CTD
PMID:14977865
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
increases glucuronidation
EXP
UGT2B15 protein results in increased glucuronidation of Ezetimibe
CTD
PMID:14977865
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UGT2B7
UDP glucuronosyltransferase family 2 member B7
increases glucuronidation
EXP
UGT2B7 protein results in increased glucuronidation of Ezetimibe
CTD
PMID:14977865
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
G
ABCB11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
EXP
Floxacillin results in decreased activity of ABCB11 protein Floxacillin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
affects binding
EXP
Floxacillin binds to ADH1B protein
CTD
PMID:36782357
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
Floxacillin results in increased expression of AKR1B10 mRNA
CTD
PMID:28444390
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
ALB
albumin
affects binding
EXP
Floxacillin binds to ALB protein
CTD
PMID:36782357
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
CASP3
caspase 3
multiple interactions increases activity
EXP
[Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Floxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CCL2
C-C motif chemokine ligand 2
increases expression
ISO
Floxacillin results in increased expression of CCL2 mRNA
CTD
PMID:24652713
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CD69
CD69 molecule
multiple interactions
ISO
[Floxacillin co-treated with CpG ODN 1826] results in decreased expression of CD69 protein
CTD
PMID:30993380
NCBI chr12:9,752,486...9,760,901
Ensembl chr12:9,752,486...9,760,901
G
CES1
carboxylesterase 1
affects binding
EXP
Floxacillin binds to CES1 protein
CTD
PMID:36782357
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CPS1
carbamoyl-phosphate synthase 1
affects binding
EXP
Floxacillin binds to CPS1 protein
CTD
PMID:36782357
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
G
CRP
C-reactive protein
multiple interactions
EXP
[Floxacillin co-treated with Gentamicins co-treated with Rifampin] results in increased expression of CRP protein
CTD
PMID:16943303
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression
ISO
Floxacillin results in increased expression of CXCL1 mRNA
CTD
PMID:24652713
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
ISO
Floxacillin results in increased expression of CXCL2 mRNA
CTD
PMID:24652713
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
increases metabolic processing
EXP
CYP3A4 results in increased metabolism of Floxacillin
CTD
PMID:11409940
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
FASLG
Fas ligand
multiple interactions
ISO
[Floxacillin co-treated with CpG ODN 1826] results in decreased expression of FASL protein; FASL protein affects the reaction [[Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein]
CTD
PMID:30993380
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
GLUD1
glutamate dehydrogenase 1
affects binding
EXP
Floxacillin binds to GLUD1 protein
CTD
PMID:36782357
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
G
GPT
glutamic--pyruvic transaminase
increases expression multiple interactions
ISO
Floxacillin results in increased expression of GPT protein [Floxacillin co-treated with alpha-galactosylceramide] results in increased expression of GPT protein; [Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein; FASL protein affects the reaction [[Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein]; IL17A protein promotes the reaction [Floxacillin results in increased expression of GPT protein]
CTD
PMID:24652713 PMID:30993380
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
HBA2
hemoglobin subunit alpha 2
affects binding
EXP
Floxacillin binds to HBA2 protein
CTD
PMID:36782357
NCBI chr16:172,876...173,710
Ensembl chr16:172,876...173,710
G
HBB
hemoglobin subunit beta
affects binding
EXP
Floxacillin binds to HBB protein
CTD
PMID:36782357
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
G
HLA-B
major histocompatibility complex, class I, B
affects response to substance
EXP
HLA-B gene polymorphism affects the susceptibility to Floxacillin
CTD
PMID:19483685
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HMGB1
high mobility group box 1
increases secretion increases expression
EXP ISO
Floxacillin results in increased secretion of HMGB1 protein Floxacillin results in increased expression of HMGB1 protein
CTD
PMID:24652713 PMID:28444390
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
IL17A
interleukin 17A
multiple interactions
ISO
[IL17A protein co-treated with Floxacillin] results in increased expression of MPO protein; IL17A protein promotes the reaction [Floxacillin results in increased expression of GPT protein]
CTD
PMID:24652713
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1A
interleukin 1 alpha
increases secretion
EXP
Floxacillin results in increased secretion of IL1A protein
CTD
PMID:28444390
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases secretion multiple interactions increases expression
EXP ISO
Floxacillin results in increased secretion of IL1B protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of IL1B mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL5
interleukin 5
increases expression
ISO
Floxacillin results in increased expression of IL5 mRNA
CTD
PMID:24652713
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL6
interleukin 6
increases secretion multiple interactions increases expression
EXP ISO
Floxacillin results in increased secretion of IL6 protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of IL6 mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
KLRF2
killer cell lectin like receptor F2
multiple interactions
ISO
[Floxacillin co-treated with CpG ODN 1826] results in decreased expression of KLRB1C protein
CTD
PMID:30993380
NCBI chr12:9,881,489...9,895,833
Ensembl chr12:9,881,489...9,895,833
G
MPO
myeloperoxidase
multiple interactions
ISO
[IL17A protein co-treated with Floxacillin] results in increased expression of MPO protein
CTD
PMID:24652713
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
RORC
RAR related orphan receptor C
increases expression
ISO
Floxacillin results in increased expression of RORC mRNA
CTD
PMID:24652713
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
S100A8
S100 calcium binding protein A8
increases expression
ISO
Floxacillin results in increased expression of S100A8 mRNA
CTD
PMID:24652713
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
increases expression
ISO
Floxacillin results in increased expression of S100A9 mRNA
CTD
PMID:24652713
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SRXN1
sulfiredoxin 1
increases expression
EXP
Floxacillin results in increased expression of SRXN1 mRNA
CTD
PMID:28444390
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
TBX21
T-box transcription factor 21
decreases expression
ISO
Floxacillin results in decreased expression of TBX21 mRNA
CTD
PMID:24652713
NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
G
TNF
tumor necrosis factor
increases secretion multiple interactions increases expression
EXP ISO
Floxacillin results in increased secretion of TNF protein [Floxacillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Floxacillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Floxacillin results in increased activity of CASP3 protein] Floxacillin results in increased expression of TNF mRNA
CTD
PMID:24652713 PMID:28444390 PMID:30876886
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TSEN2
tRNA splicing endonuclease subunit 2
affects binding
EXP
Floxacillin binds to TSEN2 protein
CTD
PMID:36782357
NCBI chr 3:12,480,231...12,539,624
Ensembl chr 3:12,484,421...12,541,549
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
Floxacillin results in increased expression of TXNRD1 mRNA
CTD
PMID:28444390
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UGP2
UDP-glucose pyrophosphorylase 2
affects binding
EXP
Floxacillin binds to UGP2 protein
CTD
PMID:36782357
NCBI chr 2:63,840,969...63,891,560
Ensembl chr 2:63,840,952...63,891,562
G
YWHAB
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
affects binding
EXP
Floxacillin binds to YWHAB protein
CTD
PMID:36782357
NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCB1A mRNA
CTD
PMID:24657338
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCG5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA
CTD
PMID:24657338
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
BAAT
bile acid-CoA:amino acid N-acyltransferase
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of BAAT mRNA
CTD
PMID:24657338
NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA
CTD
PMID:24657338
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr 7:44,512,535...44,541,330
Ensembl chr 7:44,512,535...44,541,330
G
NR0B2
nuclear receptor subfamily 0 group B member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA
CTD
PMID:24657338
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Imipenem results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR5A2
nuclear receptor subfamily 5 group A member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
SLC10A1
solute carrier family 10 member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC27A5
solute carrier family 27 member 5
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC27A5 mRNA
CTD
PMID:24657338
NCBI chr19:58,498,333...58,511,992
Ensembl chr19:58,479,512...58,512,413
G
SLC51A
solute carrier family 51 member A
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of SLC51A mRNA
CTD
PMID:24657338
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO2B1 mRNA
CTD
PMID:24657338
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
G
HLA-DOB
major histocompatibility complex, class II, DO beta
affects expression
EXP
meropenem affects the expression of HLA-DOB mRNA
CTD
PMID:25811541
NCBI chr 6:32,812,763...32,817,002
Ensembl chr 6:32,812,763...32,820,466
G
HLA-G
major histocompatibility complex, class I, G
affects expression
EXP
meropenem affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
CASP3
caspase 3
multiple interactions increases activity
EXP
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [Nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
increases expression
EXP
Nafcillin results in increased expression of CYP3A4 mRNA; Nafcillin results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
IL1B
interleukin 1 beta
multiple interactions
EXP
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL1B protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions
EXP
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with IL6 protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
Nafcillin results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
TNF
tumor necrosis factor
multiple interactions
EXP
[Nafcillin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Nafcillin co-treated with TNF protein] results in increased activity of CASP3 protein; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [Nafcillin results in increased activity of CASP3 protein]
CTD
PMID:30876886
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CES1
carboxylesterase 1
increases expression
EXP
Penicillin V results in increased expression of CES1 mRNA
CTD
PMID:22609641
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
Penicillin V results in increased expression of CXCL8 mRNA; Penicillin V results in increased expression of CXCL8 protein
CTD
PMID:22609641
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
increases expression
EXP
Penicillin V results in increased expression of CYP3A4 mRNA; Penicillin V results in increased expression of CYP3A4 protein
CTD
PMID:18505790
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
Penicillin V results in increased expression of GCLM mRNA
CTD
PMID:22609641
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
MIR185
microRNA 185
decreases expression
ISO
Penicillin V results in decreased expression of MIR185 mRNA
CTD
PMID:22112502
NCBI chr22:20,033,139...20,033,220
Ensembl chr22:20,033,139...20,033,220
G
MIR296
microRNA 296
decreases expression
ISO
Penicillin V results in decreased expression of MIR296 mRNA
CTD
PMID:22112502
NCBI chr20:58,817,615...58,817,694
Ensembl chr20:58,817,615...58,817,694
G
MIR330
microRNA 330
decreases expression
ISO
Penicillin V results in decreased expression of MIR330 mRNA
CTD
PMID:22112502
NCBI chr19:45,638,994...45,639,087
Ensembl chr19:45,638,994...45,639,087
G
MIR34C
microRNA 34c
decreases expression
ISO
Penicillin V results in decreased expression of MIR34C mRNA
CTD
PMID:22112502
NCBI chr11:111,513,439...111,513,515
Ensembl chr11:111,513,439...111,513,515
G
MIR433
microRNA 433
decreases expression
ISO
Penicillin V results in decreased expression of MIR433 mRNA
CTD
PMID:22112502
NCBI chr14:100,881,886...100,881,978
Ensembl chr14:100,881,886...100,881,978
G
MIR484
microRNA 484
decreases expression
ISO
Penicillin V results in decreased expression of MIR484 mRNA
CTD
PMID:22112502
NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Penicillin V results in increased expression of NQO1 mRNA
CTD
PMID:22609641
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
PIR
pirin
increases expression
EXP
Penicillin V results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
TRIM16
tripartite motif containing 16
increases expression
EXP
Penicillin V results in increased expression of TRIM16 mRNA
CTD
PMID:22609641
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Piperacillin
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
multiple interactions decreases activity
EXP
Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] Piperacillin results in decreased activity of CYP2C8 protein
CTD
PMID:26763401
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
HLA-DMB
major histocompatibility complex, class II, DM beta
affects expression
EXP
Piperacillin affects the expression of HLA-DMB mRNA
CTD
PMID:25811541
NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
G
IFNG
interferon gamma
increases secretion
EXP
Piperacillin results in increased secretion of IFNG protein
CTD
PMID:29644860
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL1B
interleukin 1 beta
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA]
CTD
PMID:16369182
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL22
interleukin 22
increases secretion
EXP
Piperacillin results in increased secretion of IL22 protein
CTD
PMID:29644860
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
MIR155
microRNA 155
increases expression
EXP
Piperacillin results in increased expression of MIR155 mRNA
CTD
PMID:29644860
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR18A
microRNA 18a
increases expression
EXP
Piperacillin results in increased expression of MIR18A mRNA
CTD
PMID:29644860
NCBI chr13:91,350,751...91,350,821
Ensembl chr13:91,350,751...91,350,821
G
MIR21
microRNA 21
increases expression
EXP
Piperacillin results in increased expression of MIR21 mRNA
CTD
PMID:29644860
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MR1
major histocompatibility complex, class I-related
affects expression
EXP
Piperacillin affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr 1:181,033,387...181,061,938
Ensembl chr 1:181,033,374...181,061,938
G
SLC25A20
solute carrier family 25 member 20
multiple interactions
ISO
Piperacillin binds to and results in decreased activity of SLC25A20 protein; Piperacillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
G
TNF
tumor necrosis factor
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA]
CTD
PMID:16369182
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases transport
EXP
ABCC4 protein results in increased transport of Sulbactam
CTD
PMID:17939016
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
IL1B
interleukin 1 beta
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA]
CTD
PMID:16369182
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
TNF
tumor necrosis factor
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA]
CTD
PMID:16369182
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all